pathogenName,outbreak,parameter,estimate,censored,estimateUnit,estimateType,lowerBound,upperBound,intervalKind,ageClass,ageMean,ageMedian,ageMin,ageMax,proportionMale,country,continent,entryAuthor,checkedby,publicationFirstAuthor,publicationYear,PMID,url,title,notes,virusType,citation,case
2019-nCoV,2019-2020 global nCoV outbreak,R0,2.2,NA,NA,NA,1.4,3.9,95% confidence interval,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Li,2020,NA,https://doi.org/10.1056/NEJMoa2001316,"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia",NA,Coronavirus,Li 2020,1
2019-nCoV,2019-2020 global nCoV outbreak,R0,2.2,NA,NA,NA,1.4,3.8,90% high density interval,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Riou,2020,NA,https://github.com/jriou/wcov/blob/master/manuscript_v2.pdf,Pattern of early human-to-human transmission of Wuahn 2019-nCoV,NA,Coronavirus,Riou 2020,2
2019-nCoV,2019-2020 global nCoV outbreak,R0,2.68,NA,NA,NA,2.47,2.86,95% credible interval,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Wu,2020,NA,https://doi.org/10.1016/S0140-6736(20)30260-9,"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study",NA,Coronavirus,Wu 2020,3
2019-nCoV,2019-2020 global nCoV outbreak,R0,2.9,NA,NA,NA,2.1,4.5,95% confidence interval,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Park,2020,NA,https://doi.org/10.1101/2020.01.30.20019877,Reconciling early-outbreak estimates of the basic reproductive number and its uncertainty: a new framework and applications to the novel coronavirus (2019-nCoV) outbreak,pooled estimates from 7 studies,Coronavirus,Park 2020,4
2019-nCoV,2019-2020 global nCoV outbreak,R0,2.1,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,CEID,2020,NA,https://ceidatuga.github.io/2019nCoV-Dashboard/parameters.html,Estimating R0 and other parameters for the 2019-nCov epidemic,estimate from takeoff,Coronavirus,CEID 2020,5
2019-nCoV,2019-2020 global nCoV outbreak,R0,NA,NA,NA,NA,1.3,3.2,range,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,CEID,2020,NA,https://ceidatuga.github.io/2019nCoV-Dashboard/parameters.html,Estimating R0 and other parameters for the 2019-nCov epidemic,estimate from exponential growth phase,Coronavirus,CEID 2020,6
2019-nCoV,2019-2020 global nCoV outbreak,R0,6.3,NA,NA,NA,3.3,11.3,95% confidence interval,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Sanche,2020,NA,https://doi.org/10.1101/2020.02.07.20021154,"The Novel Coronavirus, 2019-nCoV, is Highly Contagious and More Infectious Than Initially Estimated","""first arrival"" approach, latent period = incubation period",Coronavirus,Sanche 2020,7
2019-nCoV,2019-2020 global nCoV outbreak,R0,4.7,NA,NA,NA,2.8,7.6,95% confidence interval,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Sanche,2020,NA,https://doi.org/10.1101/2020.02.07.20021154,"The Novel Coronavirus, 2019-nCoV, is Highly Contagious and More Infectious Than Initially Estimated","""first arrival"" approach, latent period = incubation period - 2",Coronavirus,Sanche 2020,8
2019-nCoV,2019-2020 global nCoV outbreak,R0,6.6,NA,NA,NA,4,10.5,95% confidence interval,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Sanche,2020,NA,https://doi.org/10.1101/2020.02.07.20021154,"The Novel Coronavirus, 2019-nCoV, is Highly Contagious and More Infectious Than Initially Estimated","""case count"" approach, latent period = incubation period",Coronavirus,Sanche 2020,9
2019-nCoV,2019-2020 global nCoV outbreak,R0,4.9,NA,NA,NA,3.3,7.2,95% confidence interval,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Sanche,2020,NA,https://doi.org/10.1101/2020.02.07.20021154,"The Novel Coronavirus, 2019-nCoV, is Highly Contagious and More Infectious Than Initially Estimated","""case count"" approach, latent period = incubation period - 2",Coronavirus,Sanche 2020,10
2019-nCoV,2019-2020 global nCoV outbreak,R0,7.05,NA,NA,NA,6.11,8.18,95% credible interval,NA,NA,NA,NA,NA,NA,China,Asia,Cecilia Sanchez,NA,Mizumoto,2020,NA,https://doi.org/10.1101/2020.02.12.20022434,"Early epidemiological assessment of the transmission potential and virulence of 2019 Novel Coronavirus in Wuhan City: China, 2019-2020","for Wuhan City, China",Coronavirus,Mizumoto 2020,11
2019-nCoV,2019-2020 global nCoV outbreak,R0,3.24,NA,NA,NA,3.16,3.32,95% credible interval,NA,NA,NA,NA,NA,NA,China,Asia,Cecilia Sanchez,NA,Mizumoto,2020,NA,https://doi.org/10.1101/2020.02.12.20022434,"Early epidemiological assessment of the transmission potential and virulence of 2019 Novel Coronavirus in Wuhan City: China, 2019-2020","for Wuhan City, China. after Jan 23, 2020, due to enhanced public health
intervention",Coronavirus,Mizumoto 2020,12
2019-nCoV,2019-2020 global nCoV outbreak,R0,2.28,NA,NA,median,2.06,2.52,95% confidence interval,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Zhang,2020,NA,https://doi.org/10.1016/j.ijid.2020.02.033,Estimation of the reproductive number of Novel Coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis,for the Diamond Princess ship,Coronavirus,Zhang 2020,13
2019-nCoV,2019-2020 global nCoV outbreak,R0,1.4,NA,NA,NA,1.04,1.85,95% confidence interval,NA,NA,NA,NA,NA,NA,China,Asia,Daniel Suh,NA,Zhang,2020,NA,https://doi.org/10.1101/2020.02.21.20026328,Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study,Shenzhen City,Coronavirus,Zhang 2020,14
2019-nCoV,2019-2020 global nCoV outbreak,R0,2.17,NA,NA,NA,1.69,2.76,95% confidence interval,NA,NA,NA,NA,NA,NA,China,Asia,Daniel Suh,NA,Zhang,2020,NA,https://doi.org/10.1101/2020.02.21.20026328,Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study,Shandong Province,Coronavirus,Zhang 2020,15
2019-nCoV,2019-2020 global nCoV outbreak,R0,1.58,NA,NA,NA,1.29,1.92,95% confidence interval,NA,NA,NA,NA,NA,NA,China,Asia,Daniel Suh,NA,Zhang,2020,NA,https://doi.org/10.1101/2020.02.21.20026328,Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study,Hunan Province,Coronavirus,Zhang 2020,16
2019-nCoV,2019-2020 global nCoV outbreak,R0,NA,NA,NA,NA,2.76,3.25,none provided,NA,NA,NA,NA,NA,NA,Italy,NA,Cecilia Sanchez,NA,Remuzzi,2020,NA,https://doi.org/10.1016/S0140-6736(20)30627-9,COVID-19 and Italy: what next?,NA,Coronavirus,Remuzzi 2020,17
2019-nCoV,2019-2020 global nCoV outbreak,R0-pre,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",18
2019-nCoV,2019-2020 global nCoV outbreak,R0-asym,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",19
2019-nCoV,2019-2020 global nCoV outbreak,days_presymptomatic,6.4,NA,days,mean,5.3,7.6,95% confidence interval,NA,NA,NA,NA,NA,NA,China,Asia,Cecilia Sanchez,NA,Lu,2020,NA,https://doi.org/10.1101/2020.02.19.20025031,"A descriptive study of the impact of diseases control and prevention on the epidemics dynamics and clinical features of SARS-CoV-2 outbreak in Shanghai, lessons learned for metropolis epidemics prevention",Shanghai,Coronavirus,Lu 2020,20
2019-nCoV,2019-2020 global nCoV outbreak,days_presymptomatic,4,NA,days,median,3,5,interquartile range,NA,NA,41,NA,NA,0.58,China,Asia,Cecilia Sanchez,NA,Xu,2020,NA,https://doi.org/10.1136/bmj.m606,"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series",NA,Coronavirus,Xu 2020,21
2019-nCoV,2019-2020 global nCoV outbreak,days_presymptomatic,4.2,NA,days,NA,3.5,5.1,95% confidence interval,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Sanche,2020,NA,https://doi.org/10.1101/2020.02.07.20021154,"The Novel Coronavirus, 2019-nCoV, is Highly Contagious and More Infectious Than Initially Estimated",NA,Coronavirus,Sanche 2020,22
2019-nCoV,2019-2020 global nCoV outbreak,days_presymptomatic,3,NA,days,median,0,24,range,NA,NA,47,NA,NA,0.581,China,Asia,Cecilia Sanchez,NA,Guan,2020,NA,https://doi.org/10.1101/2020.02.06.20020974,Clinical characteristics of 2019 novel coronavirus infection in China,NA,Coronavirus,Guan 2020,23
2019-nCoV,2019-2020 global nCoV outbreak,days_presymptomatic,4.6,NA,days,median,3.3,5.7,95% confidence interval,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Linton,2020,NA,http://dx.doi.org/10.1101/2020.01.26.20018754,Epidemiological characteristics of novel coronavirus infection: A statistical analysis of publicly available case data,excluding Wuhan residents,Coronavirus,Linton 2020,24
2019-nCoV,2019-2020 global nCoV outbreak,days_presymptomatic,5,NA,days,median,4.1,5.8,95% confidence interval,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Linton,2020,NA,http://dx.doi.org/10.1101/2020.01.26.20018754,Epidemiological characteristics of novel coronavirus infection: A statistical analysis of publicly available case data,including Wuhan residents,Coronavirus,Linton 2020,25
2019-nCoV,2019-2020 global nCoV outbreak,days_presymptomatic,5.2,NA,days,mean,4.1,7,95% confidence interval,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Li,2020,NA,https://doi.org/10.1056/NEJMoa2001316,"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia",NA,Coronavirus,Li 2020,26
2019-nCoV,2019-2020 global nCoV outbreak,days_presymptomatic,5.1,NA,days,median,4.5,5.8,95% confidence interval,NA,NA,44.5,NA,NA,0.6,NA,NA,Cecilia Sanchez,NA,Lauer,2020,NA,https://doi.org/10.7326/M20-0504,The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application,"108 cases from 24 countries/regions outside China, 73 cases from 25 provinces
within mainland China",Coronavirus,Lauer 2020,27
2019-nCoV,2019-2020 global nCoV outbreak,days_presymptomatic,6.4,NA,days,mean,5.6,7.7,95% credible interval,NA,NA,NA,2,72,0.648,NA,NA,Cecilia Sanchez,NA,Backer,2020,NA,https://doi.org/10.2807/1560-7917.ES.2020.25.5.2000062,"Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020",NA,Coronavirus,Backer 2020,28
2019-nCoV,2019-2020 global nCoV outbreak,days_presymptomatic,NA,NA,days,NA,3,6,range,NA,NA,NA,NA,NA,NA,China,Asia,Cecilia Sanchez,NA,Chan,2020,NA,https://doi.org/10.1016/S0140-6736(20)30154-9,A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster,NA,Coronavirus,Chan 2020,29
2019-nCoV,2019-2020 global nCoV outbreak,days_presymptomatic,5.515,NA,days,mean,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,CEID,2020,NA,https://ceidatuga.github.io/2019nCoV-Dashboard/parameters.html,Estimating R0 and other parameters for the 2019-nCov epidemic,NA,Coronavirus,CEID 2020,30
2019-nCoV,2019-2020 global nCoV outbreak,days_presymptomatic,4,NA,days,median,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,CEID,2020,NA,https://ceidatuga.github.io/2019nCoV-Dashboard/parameters.html,Estimating R0 and other parameters for the 2019-nCov epidemic,NA,Coronavirus,CEID 2020,31
2019-nCoV,2019-2020 global nCoV outbreak,days_presymptomatic,5.2,NA,days,mean,1.8,12.4,95% confidence interval,NA,NA,44,1,97,NA,China,Asia,Daniel Suh,NA,Zhang,2020,NA,https://doi.org/10.1101/2020.02.21.20026328,Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study,NA,Coronavirus,Zhang 2020,32
2019-nCoV,2019-2020 global nCoV outbreak,days_presymptomatic,4,NA,days,NA,2,7,range,NA,NA,47,34,71,0.581,China,Asia,Daniel Suh,NA,Guan,2020,NA,https://doi.org/10.1056/NEJMoa2002032,Clinical Characteristics of Coronavirus Disease 2019 in China,NA,Coronavirus,Guan 2020,33
2019-nCoV,2019-2020 global nCoV outbreak,days_symptomatic,14,NA,days,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Xu,2020,NA,https://doi.org/10.1016/S2213-2600(20)30076-X,Pathological findings of COVID-19 associated with acute respiratory distress syndrome,cough. case study.,Coronavirus,Xu 2020,34
2019-nCoV,2019-2020 global nCoV outbreak,days_symptomatic,9,NA,days,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Xu,2020,NA,https://doi.org/10.1016/S2213-2600(20)30076-X,Pathological findings of COVID-19 associated with acute respiratory distress syndrome,chills. case study.,Coronavirus,Xu 2020,35
2019-nCoV,2019-2020 global nCoV outbreak,days_symptomatic,3,NA,days,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Xu,2020,NA,https://doi.org/10.1016/S2213-2600(20)30076-X,Pathological findings of COVID-19 associated with acute respiratory distress syndrome,fever. case study.,Coronavirus,Xu 2020,36
2019-nCoV,2019-2020 global nCoV outbreak,days_symptomatic,7,NA,days,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Xu,2020,NA,https://doi.org/10.1016/S2213-2600(20)30076-X,Pathological findings of COVID-19 associated with acute respiratory distress syndrome,fatigue. case study.,Coronavirus,Xu 2020,37
2019-nCoV,2019-2020 global nCoV outbreak,days_symptomatic,7,NA,days,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Xu,2020,NA,https://doi.org/10.1016/S2213-2600(20)30076-X,Pathological findings of COVID-19 associated with acute respiratory distress syndrome,shortness of breath. case study.,Coronavirus,Xu 2020,38
2019-nCoV,2019-2020 global nCoV outbreak,days_infectious,9.5,NA,days,median,1,21,range,NA,NA,32.5,5,95,0.333,China,Asia,Cecilia Sanchez,NA,Hu,2020,NA,https://doi.org/10.1101/2020.02.20.20025619,"Clinical Characteristics of 24 Asymptomatic Infections with COVID-19 Screened among Close Contacts in Nanjing, China","measured the communicable period, defined as the interval from the first day of
positive nucleic acid tests (of pharyngeal swabs) to the first day of continuous
negative tests, in 24 asymptomatic patients",Coronavirus,Hu 2020,39
2019-nCoV,2019-2020 global nCoV outbreak,days_infectious,16,NA,days,maximum,NA,NA,none provided,NA,NA,NA,NA,NA,NA,China,Asia,Cecilia Sanchez,NA,Pan,2020,NA,https://doi.org/10.1016/S1473-3099(20)30113-4,Viral load of SARS-CoV-2 in clinical samples,throat swab,Coronavirus,Pan 2020,40
2019-nCoV,2019-2020 global nCoV outbreak,days_infectious,18,NA,days,maximum,NA,NA,none provided,NA,NA,NA,NA,NA,NA,Germany,NA,Cecilia Sanchez,NA,Woelfel,2020,NA,https://doi.org/10.1101/2020.03.05.20030502,Virological assessment of hospitalized cases of coronavirus disease 2019,"based on Fig. 2 panel a, showing positive viral load from days 4-22 post-symptom
onset",Coronavirus,Woelfel 2020,41
2019-nCoV,2019-2020 global nCoV outbreak,days_infectious,20,NA,days,median,17,24,interquartile range,NA,NA,52,NA,NA,0.59,China,Asia,Cecilia Sanchez,NA,Zhou,2020,NA,https://doi.org/10.1016/S0140-6736(20)30566-3,"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study",duration of viral shedding in survivors,Coronavirus,Zhou 2020,42
2019-nCoV,2019-2020 global nCoV outbreak,generation_time,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",43
2019-nCoV,2019-2020 global nCoV outbreak,serial_interval_sym,4,NA,days,median,3.1,4.9,95% credible interval,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Nishiura,2020,NA,https://doi.org/10.1016/j.ijid.2020.02.060,Serial interval of novel coronavirus (COVID-19) infections,all pairs (n = 28),Coronavirus,Nishiura 2020,44
2019-nCoV,2019-2020 global nCoV outbreak,serial_interval_sym,4.6,NA,days,median,3.5,5.9,95% credible interval,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Nishiura,2020,NA,https://doi.org/10.1016/j.ijid.2020.02.060,Serial interval of novel coronavirus (COVID-19) infections,highest certainty pairs (n = 18),Coronavirus,Nishiura 2020,45
2019-nCoV,2019-2020 global nCoV outbreak,serial_interval_sym,7.5,NA,days,mean,5.3,19,95% confidence interval,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Li,2020,NA,https://doi.org/10.1056/NEJMoa2001316,"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia",NA,Coronavirus,Li 2020,46
2019-nCoV,2019-2020 global nCoV outbreak,serial_interval_sym,5.1,NA,days,mean,1.3,11.6,95% confidence interval,NA,NA,44,1,97,NA,China,Asia,Daniel Suh,NA,Zhang,2020,NA,https://doi.org/10.1101/2020.02.21.20026328,Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study,NA,Coronavirus,Zhang 2020,47
2019-nCoV,2019-2020 global nCoV outbreak,prop_asymptomatic,4.15,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,China,Asia,Cecilia Sanchez,NA,Lu,2020,NA,https://doi.org/10.1101/2020.02.19.20025031,"A descriptive study of the impact of diseases control and prevention on the epidemics dynamics and clinical features of SARS-CoV-2 outbreak in Shanghai, lessons learned for metropolis epidemics prevention",Shanghai. Eleven patients were asymptomatic on admission,Coronavirus,Lu 2020,48
2019-nCoV,2019-2020 global nCoV outbreak,prop_asymptomatic,50,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Nishiura,2020,NA,https://doi.org/10.1101/2020.02.03.20020248,Estimation of the asymptomatic ratio of novel coronavirus (2019-nCoV) infections among passengers on evacuation flights,NA,Coronavirus,Nishiura 2020,49
2019-nCoV,2019-2020 global nCoV outbreak,prop_asymptomatic,3.13852813852814,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,World Health Organization,2020,NA,https://reliefweb.int/sites/reliefweb.int/files/resources/20200219-sitrep-30-covid-19.pdf,NA,"""Of the 924 cases reported outside China, 29 were detected while apparently
asymptomatic""",Coronavirus,World Health Organization 2020,50
2019-nCoV,2019-2020 global nCoV outbreak,prop_asymptomatic,19.2,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,"Japan Ministry of Health, Labour and Welfare",2020,NA,https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/newpage_00032.html,About Coronavirus Disease 2019 (COVID 2019),14 of 73 PCR positive had no symptoms,Coronavirus,"Japan Ministry of Health, Labour and Welfare 2020",51
2019-nCoV,2019-2020 global nCoV outbreak,prop_asymptomatic,76.3,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Fang,2020,NA,https://www.ntd.com/japan-and-south-korea-report-big-jump-in-novel-coronavirus-cases_436547.html,Japan and South Korea report big jump in novel coronavirus cases,"From 3 dates of testing on the Diamond Princess: 68/79, 65/88, and 70/99 did not
have symptoms (= 203/266 total)",Coronavirus,Fang 2020,52
2019-nCoV,2019-2020 global nCoV outbreak,prop_asymptomatic,1.23,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,0.514,China,Asia,Cecilia Sanchez,NA,Zhang,2020,NA,http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51,"Vital Surveillances: The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020","All COVID-19 cases in China reported through Feb. 11, 2020 (n = 72314 cases)",Coronavirus,Zhang 2020,53
2019-nCoV,2019-2020 global nCoV outbreak,prop_asymptomatic,34.6,NA,NA,percent,29.4,39.8,95% credible interval,NA,NA,NA,NA,NA,0.502,NA,NA,Cecilia Sanchez,NA,Mizumoto,2020,NA,https://doi.org/10.1101/2020.02.20.20025866,"Estimating the Asymptomatic Ratio of 2019 Novel Coronavirus onboard the Princess Cruises Ship, 2020",NA,Coronavirus,Mizumoto 2020,54
2019-nCoV,2019-2020 global nCoV outbreak,prop_asymptomatic,10.6824925816024,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,Japan,Asia,Cecilia Sanchez,NA,NA,2020,NA,https://www.mhlw.go.jp/stf/newpage_10173.html,NA,as of March 12,Coronavirus,"NA 2020",55
2019-nCoV,2019-2020 global nCoV outbreak,prop_symptomatic,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",56
2019-nCoV,2019-2020 global nCoV outbreak,prop_inf_fever,90.9,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,China,Asia,Cecilia Sanchez,NA,Lu,2020,NA,https://doi.org/10.1101/2020.02.19.20025031,"A descriptive study of the impact of diseases control and prevention on the epidemics dynamics and clinical features of SARS-CoV-2 outbreak in Shanghai, lessons learned for metropolis epidemics prevention",Shanghai,Coronavirus,Lu 2020,57
2019-nCoV,2019-2020 global nCoV outbreak,prop_inf_cough,49.4,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,China,Asia,Cecilia Sanchez,NA,Lu,2020,NA,https://doi.org/10.1101/2020.02.19.20025031,"A descriptive study of the impact of diseases control and prevention on the epidemics dynamics and clinical features of SARS-CoV-2 outbreak in Shanghai, lessons learned for metropolis epidemics prevention",Shanghai,Coronavirus,Lu 2020,58
2019-nCoV,2019-2020 global nCoV outbreak,prop_inf_hospitalized,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",59
2019-nCoV,2019-2020 global nCoV outbreak,prop_inf_critical,18.3411580594679,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,China,Asia,Joy Vaz,NA,WHO,2020,NA,https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200212-sitrep-23-ncov.pdf?sfvrsn=41e9fb78_4,NA,"described as ""severe"" cases. as of Feb 12",Coronavirus,WHO 2020,60
2019-nCoV,2019-2020 global nCoV outbreak,prop_inf_critical,3.8,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,China,Asia,Cecilia Sanchez,NA,Lu,2020,NA,https://doi.org/10.1101/2020.02.19.20025031,"A descriptive study of the impact of diseases control and prevention on the epidemics dynamics and clinical features of SARS-CoV-2 outbreak in Shanghai, lessons learned for metropolis epidemics prevention","Shanghai. By February 11. ""severe""",Coronavirus,Lu 2020,61
2019-nCoV,2019-2020 global nCoV outbreak,prop_inf_critical,4.5,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,China,Asia,Cecilia Sanchez,NA,Lu,2020,NA,https://doi.org/10.1101/2020.02.19.20025031,"A descriptive study of the impact of diseases control and prevention on the epidemics dynamics and clinical features of SARS-CoV-2 outbreak in Shanghai, lessons learned for metropolis epidemics prevention","Shanghai. By February 11. ""critically ill"" (requiring invasive mechanical
ventilation)",Coronavirus,Lu 2020,62
2019-nCoV,2019-2020 global nCoV outbreak,prop_inf_critical,NA,NA,NA,percent,9,11,none provided,NA,NA,NA,NA,NA,NA,Italy,NA,Cecilia Sanchez,NA,Remuzzi,2020,NA,https://doi.org/10.1016/S0140-6736(20)30627-9,COVID-19 and Italy: what next?,patients admitted to intensive care untis from March 1 - 11,Coronavirus,Remuzzi 2020,63
2019-nCoV,2019-2020 global nCoV outbreak,prop_inf_death,0.9,NA,NA,percent,0.5,4,none provided,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Dorigatti,2020,NA,https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-2019-nCoV-severity-10-02-2020.pdf,Report 4: Severity of 2019-novel coronavirus (nCoV),assuming infected individuals test positive for 14 days,Coronavirus,Dorigatti 2020,64
2019-nCoV,2019-2020 global nCoV outbreak,prop_inf_death,0.8,NA,NA,percent,0.4,3,none provided,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Dorigatti,2020,NA,https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-2019-nCoV-severity-10-02-2020.pdf,Report 4: Severity of 2019-novel coronavirus (nCoV),assuming infected individuals test positive for 7 days,Coronavirus,Dorigatti 2020,65
2019-nCoV,2019-2020 global nCoV outbreak,prop_inf_death,0.07,NA,NA,percent,0.05,0.09,none provided,NA,NA,NA,NA,NA,NA,China,Asia,Cecilia Sanchez,NA,Mizumoto,2020,NA,https://doi.org/10.1101/2020.02.12.20022434,"Early epidemiological assessment of the transmission potential and virulence of 2019 Novel Coronavirus in Wuhan City: China, 2019-2020","for Wuhan, China. time-delay not adjusted IFR",Coronavirus,Mizumoto 2020,66
2019-nCoV,2019-2020 global nCoV outbreak,prop_inf_death,0.23,NA,NA,percent,0.17,0.3,none provided,NA,NA,NA,NA,NA,NA,China,Asia,Cecilia Sanchez,NA,Mizumoto,2020,NA,https://doi.org/10.1101/2020.02.12.20022434,"Early epidemiological assessment of the transmission potential and virulence of 2019 Novel Coronavirus in Wuhan City: China, 2019-2020","for Wuhan, China. time-delay adjusted IFR",Coronavirus,Mizumoto 2020,67
2019-nCoV,2019-2020 global nCoV outbreak,prop_sym_fever,98.6,NA,NA,percent,NA,NA,none provided,NA,NA,56,22,92,0.543,China,Asia,Cecilia Sanchez,NA,Wang,2020,NA,https://doi.org/10.1001/jama.2020.1585,"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China",all hospitalized,Coronavirus,Wang 2020,68
2019-nCoV,2019-2020 global nCoV outbreak,prop_sym_fever,97.6,NA,NA,percent,NA,NA,none provided,NA,NA,49,NA,NA,0.732,China,Asia,Cecilia Sanchez,NA,Huang,2020,NA,https://doi.org/10.1016/S0140-6736(20)30183-5,"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",all hospitalized,Coronavirus,Huang 2020,69
2019-nCoV,2019-2020 global nCoV outbreak,prop_sym_fever,87.9,NA,NA,percent,NA,NA,none provided,NA,NA,47,NA,NA,0.581,China,Asia,Cecilia Sanchez,NA,Guan,2020,NA,https://doi.org/10.1101/2020.02.06.20020974,Clinical characteristics of 2019 novel coronavirus infection in China,NA,Coronavirus,Guan 2020,70
2019-nCoV,2019-2020 global nCoV outbreak,prop_sym_fever,77,NA,NA,percent,NA,NA,none provided,NA,NA,41,NA,NA,0.58,China,Asia,Cecilia Sanchez,NA,Xu,2020,NA,https://doi.org/10.1136/bmj.m606,"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series",NA,Coronavirus,Xu 2020,71
2019-nCoV,2019-2020 global nCoV outbreak,prop_sym_fever,88.7,NA,NA,percent,NA,NA,none provided,NA,NA,47,34,71,0.581,China,Asia,Daniel Suh,NA,Guan,2020,NA,https://doi.org/10.1056/NEJMoa2002032,Clinical Characteristics of Coronavirus Disease 2019 in China,NA,Coronavirus,Guan 2020,72
2019-nCoV,2019-2020 global nCoV outbreak,prop_sym_cough,59.4,NA,NA,percent,NA,NA,none provided,NA,NA,56,22,92,0.543,China,Asia,Cecilia Sanchez,NA,Wang,2020,NA,https://doi.org/10.1001/jama.2020.1585,"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China",all hospitalized,Coronavirus,Wang 2020,73
2019-nCoV,2019-2020 global nCoV outbreak,prop_sym_cough,75.6,NA,NA,percent,NA,NA,none provided,NA,NA,49,NA,NA,0.732,China,Asia,Cecilia Sanchez,NA,Huang,2020,NA,https://doi.org/10.1016/S0140-6736(20)30183-5,"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",all hospitalized,Coronavirus,Huang 2020,74
2019-nCoV,2019-2020 global nCoV outbreak,prop_sym_cough,67.7,NA,NA,percent,NA,NA,none provided,NA,NA,47,NA,NA,0.581,China,Asia,Cecilia Sanchez,NA,Guan,2020,NA,https://doi.org/10.1101/2020.02.06.20020974,Clinical characteristics of 2019 novel coronavirus infection in China,NA,Coronavirus,Guan 2020,75
2019-nCoV,2019-2020 global nCoV outbreak,prop_sym_cough,81,NA,NA,percent,NA,NA,none provided,NA,NA,41,NA,NA,0.58,China,Asia,Cecilia Sanchez,NA,Xu,2020,NA,https://doi.org/10.1136/bmj.m606,"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series",NA,Coronavirus,Xu 2020,76
2019-nCoV,2019-2020 global nCoV outbreak,prop_sym_cough,67.8,NA,NA,percent,NA,NA,none provided,NA,NA,47,34,71,0.581,China,Asia,Daniel Suh,NA,Guan,2020,NA,https://doi.org/10.1056/NEJMoa2002032,Clinical Characteristics of Coronavirus Disease 2019 in China,NA,Coronavirus,Guan 2020,77
2019-nCoV,2019-2020 global nCoV outbreak,prop_sym_hospitalized,82.3,NA,NA,percent,NA,NA,none provided,NA,NA,47,NA,NA,0.581,China,Asia,Cecilia Sanchez,NA,Guan,2020,NA,https://doi.org/10.1101/2020.02.06.20020974,Clinical characteristics of 2019 novel coronavirus infection in China,NA,Coronavirus,Guan 2020,78
2019-nCoV,2019-2020 global nCoV outbreak,prop_sym_critical,1.6,NA,NA,percent,NA,NA,none provided,NA,NA,41,NA,NA,0.58,China,Asia,Cecilia Sanchez,NA,Xu,2020,NA,https://doi.org/10.1136/bmj.m606,"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series",only 1 patient of 62 admitted to intensive care unit,Coronavirus,Xu 2020,79
2019-nCoV,2019-2020 global nCoV outbreak,prop_sym_critical,4.67,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,0.514,China,Asia,David Vasquez,NA,Zhang,2020,NA,http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51,"Vital Surveillances: The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020",2087/44672 confirmed symptomatic critical cases,Coronavirus,Zhang 2020,80
2019-nCoV,2019-2020 global nCoV outbreak,prop_sym_critical,6.1,NA,NA,percent,NA,NA,none provided,NA,NA,47,34,71,0.581,China,Asia,Daniel Suh,NA,Guan,2020,NA,https://doi.org/10.1056/NEJMoa2002032,Clinical Characteristics of Coronavirus Disease 2019 in China,NA,Coronavirus,Guan 2020,81
2019-nCoV,2019-2020 global nCoV outbreak,prop_sym_death,4.3,R,NA,percent,NA,NA,none provided,NA,NA,56,22,92,0.543,China,Asia,Cecilia Sanchez,NA,Wang,2020,NA,https://doi.org/10.1001/jama.2020.1585,"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China",NA,Coronavirus,Wang 2020,82
2019-nCoV,2019-2020 global nCoV outbreak,prop_sym_death,14.6,R,NA,percent,NA,NA,none provided,NA,NA,49,NA,NA,0.732,China,Asia,Cecilia Sanchez,NA,Huang,2020,NA,https://doi.org/10.1016/S0140-6736(20)30183-5,"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",NA,Coronavirus,Huang 2020,83
2019-nCoV,2019-2020 global nCoV outbreak,prop_sym_death,1.4,R,NA,percent,NA,NA,none provided,NA,NA,47,NA,NA,0.581,China,Asia,Cecilia Sanchez,NA,Guan,2020,NA,https://doi.org/10.1101/2020.02.06.20020974,Clinical characteristics of 2019 novel coronavirus infection in China,NA,Coronavirus,Guan 2020,84
2019-nCoV,2019-2020 global nCoV outbreak,prop_sym_death,2.91864283108355,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,China,Asia,Joy Vaz,NA,WHO,2020,NA,https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200127-sitrep-7-2019--ncov.pdf,NA,NA,Coronavirus,WHO 2020,85
2019-nCoV,2019-2020 global nCoV outbreak,prop_sym_death,2.19640434192673,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,China,Asia,Joy Vaz,NA,WHO,2020,NA,https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200127-sitrep-7-2019--ncov.pdf,NA,NA,Coronavirus,WHO 2020,86
2019-nCoV,2019-2020 global nCoV outbreak,prop_sym_death,18.9,NA,NA,percent,17.1,20.8,95% credible interval,NA,NA,NA,NA,NA,NA,NA,Asia,Cecilia Sanchez,NA,Mizumoto,2020,NA,https://doi.org/10.1101/2020.02.19.20025163,"Estimating the risk of 2019 Novel Coronavirus death during the course of the outbreak in China, 2020",in Wuhan City,Coronavirus,Mizumoto 2020,87
2019-nCoV,2019-2020 global nCoV outbreak,prop_sym_death,6.1,NA,NA,percent,5.2,7.1,95% credible interval,NA,NA,NA,NA,NA,NA,NA,Asia,Cecilia Sanchez,NA,Mizumoto,2020,NA,https://doi.org/10.1101/2020.02.19.20025163,"Estimating the risk of 2019 Novel Coronavirus death during the course of the outbreak in China, 2020","in Hubei Province, excluding Wuhan City",Coronavirus,Mizumoto 2020,88
2019-nCoV,2019-2020 global nCoV outbreak,prop_sym_death,0.9,NA,NA,percent,0.6,1.3,95% credible interval,NA,NA,NA,NA,NA,NA,NA,Asia,Cecilia Sanchez,NA,Mizumoto,2020,NA,https://doi.org/10.1101/2020.02.19.20025163,"Estimating the risk of 2019 Novel Coronavirus death during the course of the outbreak in China, 2020","in China, excluding Hubei Province",Coronavirus,Mizumoto 2020,89
2019-nCoV,2019-2020 global nCoV outbreak,prop_sym_death,2.29,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,0.514,China,Asia,David Vasquez,NA,Zhang,2020,NA,http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51,"Vital Surveillances: The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020","reported as confirmed cases / deaths. Asymptomatic cases were listed as a
separate category so the confirmed cases value are symptomatic cases",Coronavirus,Zhang 2020,90
2019-nCoV,2019-2020 global nCoV outbreak,prop_hospitalized_death,1.4,NA,NA,percent,NA,NA,none provided,NA,NA,47,34,71,0.581,China,Asia,Daniel Suh,NA,Guan,2020,NA,https://doi.org/10.1056/NEJMoa2002032,Clinical Characteristics of Coronavirus Disease 2019 in China,NA,Coronavirus,Guan 2020,91
2019-nCoV,2019-2020 global nCoV outbreak,prop_critical_death,61.5,R,NA,NA,NA,NA,none provided,NA,59.7,NA,NA,NA,0.67,China,Asia,Cecilia Sanchez,NA,Yang,2020,NA,https://doi.org/10.1016/S2213-2600(20)30079-5,"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","study population was 52 critically ill adult patients with SARS-CoV-2 pneumonia
who were admitted to the intensive care unit",Coronavirus,Yang 2020,92
2019-nCoV,2019-2020 global nCoV outbreak,prop_critical_death,100,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,0.514,China,Asia,David Vasquez,NA,Zhang,2020,NA,http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51,"Vital Surveillances: The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020",all reported deaths were in critical condition,Coronavirus,Zhang 2020,93
2019-nCoV,2019-2020 global nCoV outbreak,prop_infection_reduction_masks,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",94
2019-nCoV,2019-2020 global nCoV outbreak,incidence,1723,NA,individuals,NA,427,4471,95% confidence interval,NA,NA,NA,NA,NA,NA,China,Asia,John Drake,NA,Imai,2020,NA,https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/2019-nCoV-outbreak-report-17-01-2020.pdf,NA,"Estimate is for January 12, 2020 in Wuhan City",Coronavirus,Imai 2020,95
2019-nCoV,2019-2020 global nCoV outbreak,incidence,75815,NA,individuals,NA,37304,130330,95% credible interval,NA,NA,NA,NA,NA,NA,China,Asia,John Drake,NA,Wu,2020,NA,https://doi.org/10.1016/S0140-6736(20)30260-9,"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study","Estimate is for January 25, 2020 in Wuhan City",Coronavirus,Wu 2020,96
2019-nCoV,2019-2020 global nCoV outbreak,incidence,1250,NA,individuals,NA,350,3000,95% credible interval,NA,NA,NA,NA,NA,NA,China,Asia,John Drake,NA,Chinazzi,2020,NA,https://www.mobs-lab.org/uploads/6/7/8/7/6787877/wuhan_novel_coronavirus__6_.pdf,NA,"Estimate is for January 17, 2020 in Wuhan City",Coronavirus,Chinazzi 2020,97
2019-nCoV,2019-2020 global nCoV outbreak,incidence,2500,NA,individuals,NA,700,5900,95% credible interval,NA,NA,NA,NA,NA,NA,China,Asia,John Drake,NA,Chinazzi,2020,NA,https://www.mobs-lab.org/uploads/6/7/8/7/6787877/wuhan_novel_coronavirus__6_.pdf,NA,"Estimate is for January 17, 2020 in Wuhan Metropolitan Area",Coronavirus,Chinazzi 2020,98
2019-nCoV,2019-2020 global nCoV outbreak,incidence,3750,NA,individuals,NA,1100,8400,95% credible interval,NA,NA,NA,NA,NA,NA,China,Asia,John Drake,NA,Chinazzi,2020,NA,https://www.mobs-lab.org/uploads/6/7/8/7/6787877/wuhan_novel_coronavirus__6_.pdf,NA,"Estimate is for January 17, 2020 in Province ""closest to Wuhan""",Coronavirus,Chinazzi 2020,99
2019-nCoV,2019-2020 global nCoV outbreak,ascertainment_rate,0.092,NA,NA,NA,0.05,0.2,95% confidence interval,NA,NA,NA,NA,NA,NA,Japan,Asia,Kate Sabey,NA,Nishiura,2020,NA,https://doi.org/10.3390/jcm9020419,NA,"Estimate based on screening of 565 Japanese citizens evacuated from Wuhan, China
between 29-31 January 2020; assuming serial interval of 7.5 days",Coronavirus,Nishiura 2020,100
2019-nCoV,2019-2020 global nCoV outbreak,ascertainment_rate,0.006,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,Iran,Asia,Kate Sabey,NA,Zhuang,2020,NA,https://www.ijidonline.com/article/S1201-9712(20)30138-7/fulltext,NA,"Estimated level by 25 February 2020 using air travel and case data from Iran to
other Middle East countries",Coronavirus,Zhuang 2020,101
2019-nCoV,2019-2020 global nCoV outbreak,ascertainment_rate,0.1959,NA,NA,median,0.1436,0.3558,interquartile range,NA,NA,NA,NA,NA,NA,China,Asia,Kate Sabey,NA,Chinazzi,2020,NA,https://doi.org/10.1101/2020.02.09.20021261,NA,Estimate for detection in mainland China before travel quarantine of Wuhan,Coronavirus,Chinazzi 2020,102
2019-nCoV,2019-2020 global nCoV outbreak,ascertainment_rate,0.029,NA,NA,NA,0.013,0.08,none provided,NA,NA,NA,NA,NA,NA,China,Asia,Kate Sabey,NA,Famulare,2020,NA,https://institutefordiseasemodeling.github.io/nCoV-public/analyses/first_adjusted_mortality_estimates_and_risk_assessment/2019-nCoV-preliminary_age_and_time_adjusted_mortality_rates_and_pandemic_risk_assessment.html,NA,"Estimate for Wuhan, China using publicly-available data through 31 January 2020",Coronavirus,Famulare 2020,103
2019-nCoV,2019-2020 global nCoV outbreak,ascertainment_rate,0.44,NA,NA,NA,0.37,0.5,95% confidence interval,NA,NA,NA,NA,NA,NA,Japan,Asia,Kate Sabey,NA,Omori,2020,NA,https://doi.org/10.1101/2020.03.09.20033183,NA,"Estimate for ascertainment rate of non-severe cases as of 28 February 2020;
""severe cases are twice more likely diagnosed and reported than other cases""",Coronavirus,Omori 2020,104
2019-nCoV,2019-2020 global nCoV outbreak,days_hospitalized,8.5,NA,days,mean,5,14,none provided,NA,NA,NA,18,64,NA,USA,North America,Cody Reynolds,NA,CDC,NA,NA,https://www.cdc.gov/mmwr/volumes/69/wr/mm6918e1.htm,"Characteristics and Clinical Outcomes of Adult Patients Hospitalized with COVID-19 — Georgia, March 2020",Estimate is for March 2020,Coronavirus,CDC NA,105
2019-nCoV,2019-2020 global nCoV outbreak,days_hospitalized,10,NA,days,mean,7,14,none provided,NA,NA,NA,42,68,NA,China,Asia,Cody Reynolds,NA,Wang,2020,NA,10.1001/jama.2020.1585,"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China","Estimate is for Feburary 2, 2020",Coronavirus,Wang 2020,106
2019-nCoV,2019-2020 global nCoV outbreak,prop_hospitalized_death,NA,NA,individuals,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,USA,North America,Cody Reynolds,NA,CDC,2020,NA,https://data.cdc.gov/d/uggs-hy5q/visualization,NA,"CDC data that reports place of death. Data here includes ""Heathcare setting:
Outpatient or Emergency Room and Inpatient"". Updated May 8th",Coronavirus,CDC 2020,107
2019-nCoV,2019-2020 global nCoV outbreak,prop_hospitalized_death,52.3809524,NA,Individuals,percent,NA,NA,none provided,NA,70,NA,43,90,NA,USA,North America,Cody Reynolds,NA,Arentz,2020,NA,10.1001/jama.2020.4326,Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State,"Estimate is for March 19, 2020",Coronavirus,Arentz 2020,108
2019-nCoV,2019-2020 global nCoV outbreak,prop_sym_hospitalized (cough),0.861,NA,Individuals,percent,NA,NA,none provided,NA,NA,NA,18,NA,NA,USA,North America,Cody Reynolds,NA,CDC,2020,NA,https://www.cdc.gov/mmwr/volumes/69/wr/mm6915e3.htm,"Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020","Estimate is for March 30, 2020 for patients with coughs",Coronavirus,CDC 2020,109
2019-nCoV,2019-2020 global nCoV outbreak,prop_sym_hospitalized (fever),0.307,NA,individuals,percent,NA,NA,none provided,NA,NA,63,0,107,NA,USA,North America,Cody Reynolds,NA,Richardson,2020,NA,10.1001/jama.2020.6775,"Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area","Estimate for April 22, 2020 for patients with fevers",Coronavirus,Richardson 2020,110
2019-nCoV,2019-2020 global nCoV outbreak,prop_sym_hospitalized,97.4,NA,individuals,percent,NA,NA,none provided,NA,NA,NA,32,82,NA,China,Asia,Cody Reynolds,NA,Zhao,2020,NA,https://doi.org/10.1101/2020.03.13.20035436,Clinical characteristics and durations of hospitalized patients with COVID-19 in Beijing: a retrospective cohort study,"Estimate is for March 30th, 2020 for patients with any symptom",Coronavirus,Zhao 2020,111
2019-nCoV,2019-2020 global nCoV outbreak,prop_asymptomatic,2.6,NA,individuals,percent,NA,NA,none provided,NA,NA,NA,32,82,NA,China,Asia,Cody Reynolds,NA,Zhao,2020,NA,https://doi.org/10.1101/2020.03.13.20035436,Clinical characteristics and durations of hospitalized patients with COVID-19 in Beijing: a retrospective cohort study,"Estimate is for March 30th, 2020 for asymptomatic patients",Coronavirus,Zhao 2020,112
2019-nCoV,2019-2020 global nCoV outbreak,prop_asymptomatic,30.8,NA,individuals,percent,7.7,54,95% confidence interval,NA,NA,NA,NA,NA,NA,China,Asia,Cody Reynolds,NA,International Society for Infectious Diseases,2020,NA,https://doi.org/10.1016/j.ijid.2020.03.020,Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19),Estimate is for 13 February 2020,Coronavirus,International Society for Infectious Diseases 2020,113
SARS-CoV,2003 global SARS outbreak,R0,3.5,NA,NA,mean,1.1,4.5,90% credible interval,NA,NA,NA,NA,NA,NA,NA,Asia,Rachel Mercaldo,NA,Lipsitch,2003,NA,https://doi.org/10.1126/science.1086616,Transmission Dynamics and Control of Severe Acute Respiratory Syndrome,NA,Coronavirus,Lipsitch 2003,114
SARS-CoV,2003 global SARS outbreak,R0,0.95,NA,NA,mean,0.67,1.23,95% confidence interval,NA,NA,NA,NA,NA,NA,NA,NA,Rachel Mercaldo,NA,Chowell,2015,26336062,https://doi.org/10.1186/s12916-015-0450-0,NA,NA,Coronavirus,Chowell 2015,115
SARS-CoV,2003 global SARS outbreak,R0,2.9,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,Hong Kong,Asia,Rachel Mercaldo,NA,WHO Consensus document (pg 26),2003,NA,https://www.who.int/csr/sars/en/WHOconsensus.pdf,NA,NA,Coronavirus,WHO Consensus document (pg 26) 2003,116
SARS-CoV,2003 global SARS outbreak,R0,2.7,NA,NA,NA,2.2,3.7,95% confidence interval,NA,NA,NA,NA,NA,NA,Hong Kong,Asia,David Vasquez,NA,Riley,2003,12766206,https://doi.org/10.1126/science.1086478,Transmission Dynamics of the Etiological Agent of SARS in Hong Kong: Impact of Public Health Interventions,estimate not including super-spreader events,Coronavirus,Riley 2003,117
SARS-CoV,2003 global SARS outbreak,R0,3.8,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,Hong Kong,Asia,David Vasquez,NA,Lekone,2008,18615412,https://doi.org/10.1002/bimj.200710431,Bayesian analysis of severe acute respiratory syndrome: the 2003 Hong Kong epidemic.,NA,Coronavirus,Lekone 2008,118
SARS-CoV,2003 global SARS outbreak,R0,1.2,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,Hong Kong,Asia,David Vasquez,NA,Massad,2005,15893110,https://doi.org/10.1016/j.mehy.2004.09.029,Forecasting versus projection models in epidemiology: The case of the SARS epidemics,NA,Coronavirus,Massad 2005,119
SARS-CoV,2003 global SARS outbreak,R0,1.32,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,Canada,North America,David Vasquez,NA,Massad,2005,15893110,https://doi.org/10.1016/j.mehy.2004.09.029,Forecasting versus projection models in epidemiology: The case of the SARS epidemics,NA,Coronavirus,Massad 2005,120
SARS-CoV,2003 global SARS outbreak,R0,2.16,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,China,Asia,David Vasquez,NA,Wang,2003,NA,https://link.springer.com/article/10.1007/BF02901756,Control dynamics of severe acute respiratory syndrome transmission,NA,Coronavirus,Wang 2003,121
SARS-CoV,2003 global SARS outbreak,R0,2.87,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,China,Asia,David Vasquez,NA,Zhang,2007,NA,https://doi.org/10.1016/j.ecolmodel.2007.01.020,The outbreak pattern of SARS cases in China as revealed by a mathematical model,NA,Coronavirus,Zhang 2007,122
SARS-CoV,2003 global SARS outbreak,R0,4.8,NA,NA,NA,2.2,8.8,95% credible interval,NA,NA,NA,NA,NA,NA,China,Asia,David Vasquez,NA,McBryde,2006,16802088,https://doi.org/10.1007/s11538-005-9005-4,Bayesian modelling of an epidemic of severe acute respiratory syndrome,Estimate based on early part of the epidemic (February and March 2003),Coronavirus,McBryde 2006,123
SARS-CoV,2003 global SARS outbreak,R0,0.75,NA,NA,NA,0.65,0.85,95% credible interval,NA,NA,NA,NA,NA,NA,China,Asia,David Vasquez,NA,McBryde,2006,16802088,https://doi.org/10.1007/s11538-005-9005-4,Bayesian modelling of an epidemic of severe acute respiratory syndrome,Estimate based on the later part of the epidemic (April and May 2003),Coronavirus,McBryde 2006,124
SARS-CoV,2003 global SARS outbreak,R0,1.5,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,Canada,North America,David Vasquez,NA,Choi,2013,14573591,https://doi.org/10.1136/jech.57.10.831,A simple approximate mathematical model to predict the number of severe acute respiratory syndrome cases and deaths,NA,Coronavirus,Choi 2013,125
SARS-CoV,2003 global SARS outbreak,R0-pre,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",126
SARS-CoV,2003 global SARS outbreak,R0-asym,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",127
SARS-CoV,2003 global SARS outbreak,days_presymptomatic,5.3,NA,days,mean,4.2,6.8,95% credible interval,NA,NA,NA,NA,NA,NA,China,Asia,David Vasquez,NA,McBryde,2006,16802088,https://doi.org/10.1007/s11538-005-9005-4,Bayesian modelling of an epidemic of severe acute respiratory syndrome,NA,Coronavirus,McBryde 2006,128
SARS-CoV,2003 global SARS outbreak,days_presymptomatic,6.37,NA,days,mean,5.29,7.75,95% confidence interval,NA,NA,NA,NA,NA,0.43,Hong Kong,Asia,David Vasquez,NA,Donnelly,2003,NA,https://doi.org/10.1016/S0140-6736(03)13410-1,NA,NA,Coronavirus,Donnelly 2003,129
SARS-CoV,2003 global SARS outbreak,days_presymptomatic,4.6,NA,days,mean,3.8,5.8,95% confidence interval,NA,NA,NA,NA,NA,NA,Hong Kong,Asia,Cali Wilson,NA,Leung,2004,15520422,https://doi.org/10.7326/0003-4819-141-9-200411020-00006,NA,NA,Coronavirus,Leung 2004,130
SARS-CoV,2003 global SARS outbreak,days_presymptomatic,NA,NA,days,NA,1,14,range,NA,NA,NA,NA,NA,NA,"China (lowerBound), Singapore (upperbound)",NA,Cecilia Sanchez; Joy Vaz,NA,WHO Consensus document (pg 8),2003,NA,https://www.who.int/csr/sars/en/WHOconsensus.pdf,NA,"""The minimum reported incubation period of 1 day was reported from China (4
cases) and Singapore (3 cases) and the maximum of 14 days was reported by
China.""",Coronavirus,WHO Consensus document (pg 8) 2003,131
SARS-CoV,2003 global SARS outbreak,days_presymptomatic,NA,NA,days,median,4,5,range,NA,NA,NA,NA,NA,NA,NA,NA,Joy Vaz,NA,WHO Consensus document (pg 8),2003,NA,https://www.who.int/csr/sars/en/WHOconsensus.pdf,NA,"""most countries""",Coronavirus,WHO Consensus document (pg 8) 2003,132
SARS-CoV,2003 global SARS outbreak,days_presymptomatic,NA,NA,days,mean,4,6,range,NA,NA,NA,NA,NA,NA,NA,NA,Joy Vaz,NA,WHO Consensus document (pg 8),2003,NA,https://www.who.int/csr/sars/en/WHOconsensus.pdf,NA,"""most countries""",Coronavirus,WHO Consensus document (pg 8) 2003,133
SARS-CoV,2003 global SARS outbreak,days_symptomatic,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",134
SARS-CoV,2003 global SARS outbreak,days_infectious,23,R,days,maximum,NA,NA,none provided,NA,39.8,NA,NA,NA,0.48,Hong Kong,Asia,Rachel Mercaldo,NA,Peiris,2003,NA,https://doi.org/10.1016/S0140-6736(03)13412-5,NA,"Peak viral load at day 10: Based on + RT-PCR test, in treated hospitalized
patients",Coronavirus,Peiris 2003,135
SARS-CoV,2003 global SARS outbreak,generation_time,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",136
SARS-CoV,2003 global SARS outbreak,serial_interval_sym,8.4,NA,days,mean,NA,NA,none provided,NA,NA,NA,NA,NA,NA,Signapore,Asia,Rachel Mercaldo,NA,Lipsitch,2003,12766207,https://doi.org/10.1126/science.1086616,Transmission Dynamics and Control of Severe Acute Respiratory Syndrome,NA,Coronavirus,Lipsitch 2003,137
SARS-CoV,2003 global SARS outbreak,prop_asymptomatic,13,NA,NA,percent,NA,NA,none provided,NA,28,NA,19,64,0.09,Signapore,Asia,Rachel Mercaldo,NA,Wilder-Smith,2005,16022801,https://doi.org/10.3201/eid1107.041165,NA,HCWs,Coronavirus,Wilder-Smith 2005,138
SARS-CoV,2003 global SARS outbreak,prop_symptomatic,0.87,NA,NA,percent,NA,NA,none provided,NA,28,NA,19,64,0.09,Signapore,Asia,Rachel Mercaldo,NA,Wilder-Smith,2005,16022801,https://doi.org/10.3201/eid1107.041165,NA,NA,Coronavirus,Wilder-Smith 2005,139
SARS-CoV,2003 global SARS outbreak,prop_inf_fever,87,NA,NA,percent,NA,NA,none provided,NA,28,NA,19,64,0.09,Signapore,Asia,Rachel Mercaldo,NA,Wilder-Smith,2005,16022801,https://doi.org/10.3201/eid1107.041165,NA,NA,Coronavirus,Wilder-Smith 2005,140
SARS-CoV,2003 global SARS outbreak,prop_inf_fever,77.4,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,North America,Rachel Mercaldo,NA,Cheng,2013,NA,https://doi.org/10.1016/j.antiviral.2013.08.016,NA,NA,Coronavirus,Cheng 2013,141
SARS-CoV,2003 global SARS outbreak,prop_inf_fever,96.8,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,Asia,Rachel Mercaldo,NA,Cheng,2013,NA,https://doi.org/10.1016/j.antiviral.2013.08.016,NA,NA,Coronavirus,Cheng 2013,142
SARS-CoV,2003 global SARS outbreak,prop_inf_fever,94,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,Hong Kong,Asia,Rachel Mercaldo,NA,Donnelly,2003,NA,https://doi.org/10.1016/S0140-6736(03)13410-1,NA,NA,Coronavirus,Donnelly 2003,143
SARS-CoV,2003 global SARS outbreak,prop_inf_cough,49.1,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,Asia,Rachel Mercaldo,NA,Cheng,2013,NA,https://doi.org/10.1016/j.antiviral.2013.08.016,NA,NA,Coronavirus,Cheng 2013,144
SARS-CoV,2003 global SARS outbreak,prop_inf_cough,69,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,North America,Rachel Mercaldo,NA,Cheng,2013,NA,https://doi.org/10.1016/j.antiviral.2013.08.016,NA,NA,Coronavirus,Cheng 2013,145
SARS-CoV,2003 global SARS outbreak,prop_inf_cough,50.4,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,Hong Kong,Asia,Rachel Mercaldo,NA,Donnelly,2003,NA,https://doi.org/10.1016/S0140-6736(03)13410-1,NA,NA,Coronavirus,Donnelly 2003,146
SARS-CoV,2003 global SARS outbreak,prop_inf_cough,87,NA,NA,percent,NA,NA,none provided,NA,28,NA,19,64,0.09,Signapore,Asia,Rachel Mercaldo,NA,Wilder-Smith,2005,16022801,https://doi.org/10.3201/eid1107.041165,NA,NA,Coronavirus,Wilder-Smith 2005,147
SARS-CoV,2003 global SARS outbreak,prop_inf_hospitalized,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",148
SARS-CoV,2003 global SARS outbreak,prop_inf_critical,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",149
SARS-CoV,2003 global SARS outbreak,prop_inf_death,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",150
SARS-CoV,2003 global SARS outbreak,prop_sym_fever,100,NA,NA,percent,NA,NA,none provided,NA,39.8,NA,NA,NA,0.48,Hong Kong,Asia,Rachel Mercaldo,NA,Peiris,2003,NA,https://doi.org/10.1016/S0140-6736(03)13412-5,NA,NA,Coronavirus,Peiris 2003,151
SARS-CoV,2003 global SARS outbreak,prop_sym_fever,100,NA,NA,percent,NA,NA,none provided,NA,28,NA,19,64,0.09,Signapore,Asia,Rachel Mercaldo,NA,Wilder-Smith,2005,16022801,https://doi.org/10.3201/eid1107.041165,NA,NA,Coronavirus,Wilder-Smith 2005,152
SARS-CoV,2003 global SARS outbreak,prop_sym_cough,29,R,NA,percent,NA,NA,none provided,NA,39.8,NA,NA,NA,0.48,Hong Kong,Asia,Rachel Mercaldo,NA,Peiris,2003,NA,https://doi.org/10.1016/S0140-6736(03)13412-5,NA,Upon admission,Coronavirus,Peiris 2003,153
SARS-CoV,2003 global SARS outbreak,prop_sym_cough,100,NA,NA,percent,NA,NA,none provided,NA,28,NA,19,64,0.09,Signapore,Asia,Rachel Mercaldo,NA,Wilder-Smith,2005,16022801,https://doi.org/10.3201/eid1107.041165,NA,NA,Coronavirus,Wilder-Smith 2005,154
SARS-CoV,2003 global SARS outbreak,prop_sym_hospitalized,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",155
SARS-CoV,2003 global SARS outbreak,prop_sym_critical,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",156
SARS-CoV,2003 global SARS outbreak,prop_sym_death,9.7,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,Vietnam,Asia,Rachel Mercaldo,NA,WHO Consensus Document (pg 11),2003,NA,https://www.who.int/csr/sars/en/WHOconsensus.pdf,NA,NA,Coronavirus,WHO Consensus Document (pg 11) 2003,157
SARS-CoV,2003 global SARS outbreak,prop_sym_death,13,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,Taiwan,Asia,Rachel Mercaldo,NA,WHO Consensus Document (pg 11),2003,NA,https://www.who.int/csr/sars/en/WHOconsensus.pdf,NA,NA,Coronavirus,WHO Consensus Document (pg 11) 2003,158
SARS-CoV,2003 global SARS outbreak,prop_sym_death,15,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,Hong Kong,Asia,Rachel Mercaldo,NA,WHO Consensus Document (pg 11),2003,NA,https://www.who.int/csr/sars/en/WHOconsensus.pdf,NA,NA,Coronavirus,WHO Consensus Document (pg 11) 2003,159
SARS-CoV,2003 global SARS outbreak,prop_sym_death,14,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,Signapore,Asia,Rachel Mercaldo,NA,WHO Consensus Document (pg 11),2003,NA,https://www.who.int/csr/sars/en/WHOconsensus.pdf,NA,NA,Coronavirus,WHO Consensus Document (pg 11) 2003,160
SARS-CoV,2003 global SARS outbreak,prop_sym_death,16.7,NA,NA,percent,NA,NA,none provided,NA,NA,75,NA,NA,NA,Canada,North America,Rachel Mercaldo,NA,WHO Consensus Document (pg 11),2003,NA,https://www.who.int/csr/sars/en/WHOconsensus.pdf,NA,NA,Coronavirus,WHO Consensus Document (pg 11) 2003,161
SARS-CoV,2003 global SARS outbreak,prop_hospitalized_death,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",162
SARS-CoV,2003 global SARS outbreak,prop_critical_death,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",163
SARS-CoV,2003 global SARS outbreak,prop_infection_reduction_masks,0.7,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,Rachel Mercaldo,NA,Cheng,2013,NA,https://doi.org/10.1016/j.antiviral.2013.08.016,NA,NA,Coronavirus,Cheng 2013,164
SARS-CoV,2003 global SARS outbreak,prop_infection_reduction_masks,0.68,NA,NA,percent,0.6,0.75,95% confidence interval,NA,NA,NA,NA,NA,NA,NA,NA,Daniel Suh,NA,Jefferson,2009,NA,doi.org/10.1136/bmj.b3675,NA,NA,Coronavirus,Jefferson 2009,165
SARS-CoV,2003 global SARS outbreak,prop_infection_reduction_masks,0.91,NA,NA,percent,0.7,0.97,95% confidence interval,NA,NA,NA,NA,NA,NA,NA,NA,Daniel Suh,NA,Jefferson,2009,NA,doi.org/10.1136/bmj.b3675,NA,N95 mask,Coronavirus,Jefferson 2009,166
H1N1 virus,2009-2010 H1N1 flu pandemic,R0,1.46,NA,NA,median,1.3,1.7,interquartile range,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Biggerstaff,2014,25186370,https://doi.org/10.1186/1471-2334-14-480,"Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature",median of 78 estimates from 57 papers,Influenza virus,Biggerstaff 2014,167
H1N1 virus,2009-2010 H1N1 flu pandemic,R0,1.58,NA,NA,NA,1.34,2.04,95% confidence interval,NA,NA,NA,NA,NA,NA,Mexico,North America,Daniel Suh,NA,Fraser,2009,19433588,https://doi.org/10.1126/science.1176062,NA,NA,Influenza virus,Fraser 2009,168
H1N1 virus,2009-2010 H1N1 flu pandemic,R0-pre,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",169
H1N1 virus,2009-2010 H1N1 flu pandemic,R0-asym,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",170
H1N1 virus,2009-2010 H1N1 flu pandemic,days_presymptomatic,2,NA,days,median,1,7,range,NA,23.4,NA,0.6,74.8,0.538,China,Asia,David Vasquez,NA,Cao,2009,NA,https://doi.org/10.1056/NEJMoa0906612,NA,NA,Influenza virus,Cao 2009,171
H1N1 virus,2009-2010 H1N1 flu pandemic,days_symptomatic,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",172
H1N1 virus,2009-2010 H1N1 flu pandemic,days_infectious,NA,NA,days,NA,6,8,range,NA,NA,NA,NA,NA,NA,NA,NA,Joy Vaz,NA,"NA",2010,NA,https://www.cdc.gov/h1n1flu/qa.htm,NA,"""This can be longer in some people, especially children and people with weakened
immune systems and in people infected with 2009 H1N1 viruses.""",Influenza virus,"NA 2010",173
H1N1 virus,2009-2010 H1N1 flu pandemic,generation_time,1.91,NA,days,mean,1.3,2.7,95% confidence interval,NA,NA,NA,NA,NA,NA,Mexico,North America,Daniel Suh,NA,Fraser,2009,19433588,https://doi.org/10.1126/science.1176062,NA,NA,Influenza virus,Fraser 2009,174
H1N1 virus,2009-2010 H1N1 flu pandemic,serial_interval_sym,2.6,NA,days,mean,2.2,3.5,95% credible interval,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Cauchemez,2009,20042753,https://doi.org/10.1056/NEJMoa0905498,NA,NA,Influenza virus,Cauchemez 2009,175
H1N1 virus,2009-2010 H1N1 flu pandemic,prop_asymptomatic,17.2,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,China,Asia,Cali Wilson,NA,Pang,2011,22000351,http://dx.doi.org/10.3201/eid1710.101344,NA,estimate is for 'close contact' subjects at start of outbreak quarantine,Influenza virus,Pang 2011,176
H1N1 virus,2009-2010 H1N1 flu pandemic,prop_symptomatic,0.86,NA,NA,percent,69,100,95% confidence interval,NA,NA,NA,NA,NA,NA,Mexico,North America,Daniel Suh,NA,Fraser,2009,19433588,https://doi.org/10.1126/science.1176062,NA,NA,Influenza virus,Fraser 2009,177
H1N1 virus,2009-2010 H1N1 flu pandemic,prop_inf_fever,67.4,NA,NA,percent,NA,NA,none provided,NA,23.4,NA,0.6,74.8,0.538,China,Asia,David Vasquez,NA,Cao,2009,NA,https://doi.org/10.1056/NEJMoa0906612,NA,NA,Influenza virus,Cao 2009,178
H1N1 virus,2009-2010 H1N1 flu pandemic,prop_inf_cough,69.5,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,China,Asia,David Vasquez,NA,Cao,2009,NA,https://doi.org/10.1056/NEJMoa0906612,NA,NA,Influenza virus,Cao 2009,179
H1N1 virus,2009-2010 H1N1 flu pandemic,prop_inf_hospitalized,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",180
H1N1 virus,2009-2010 H1N1 flu pandemic,prop_inf_critical,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",181
H1N1 virus,2009-2010 H1N1 flu pandemic,prop_inf_death,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",182
H1N1 virus,2009-2010 H1N1 flu pandemic,prop_sym_fever,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",183
H1N1 virus,2009-2010 H1N1 flu pandemic,prop_sym_cough,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",184
H1N1 virus,2009-2010 H1N1 flu pandemic,prop_sym_hospitalized,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",185
H1N1 virus,2009-2010 H1N1 flu pandemic,prop_sym_critical,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",186
H1N1 virus,2009-2010 H1N1 flu pandemic,prop_sym_death,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",187
H1N1 virus,2009-2010 H1N1 flu pandemic,prop_hospitalized_death,15.1,NA,NA,percent,12.6,17.9,95% confidence interval,NA,NA,NA,NA,NA,NA,NA,Australia,David Vasquez,NA,Duggal,2016,27170999,https://doi.org/10.1371/journal.pone.0155044,NA,NA,Influenza virus,Duggal 2016,188
H1N1 virus,2009-2010 H1N1 flu pandemic,prop_hospitalized_death,27.3,NA,NA,percent,23.6,31.4,95% confidence interval,NA,NA,NA,NA,NA,NA,NA,Europe,David Vasquez,NA,Duggal,2016,27170999,https://doi.org/10.1371/journal.pone.0155044,NA,NA,Influenza virus,Duggal 2016,189
H1N1 virus,2009-2010 H1N1 flu pandemic,prop_hospitalized_death,27.4,NA,NA,percent,23.6,31.6,95% confidence interval,NA,NA,NA,NA,NA,NA,NA,North America,David Vasquez,NA,Duggal,2016,27170999,https://doi.org/10.1371/journal.pone.0155044,NA,NA,Influenza virus,Duggal 2016,190
H1N1 virus,2009-2010 H1N1 flu pandemic,prop_hospitalized_death,36.7,NA,NA,percent,29.5,44.6,95% confidence interval,NA,NA,NA,NA,NA,NA,NA,South America,David Vasquez,NA,Duggal,2016,27170999,https://doi.org/10.1371/journal.pone.0155044,NA,NA,Influenza virus,Duggal 2016,191
H1N1 virus,2009-2010 H1N1 flu pandemic,prop_hospitalized_death,36.9,NA,NA,percent,30.6,43.6,95% confidence interval,NA,NA,NA,NA,NA,NA,NA,Asia,David Vasquez,NA,Duggal,2016,27170999,https://doi.org/10.1371/journal.pone.0155044,NA,NA,Influenza virus,Duggal 2016,192
H1N1 virus,2009-2010 H1N1 flu pandemic,prop_hospitalized_death,41.8,NA,NA,percent,22.9,63.5,95% confidence interval,NA,NA,NA,NA,NA,NA,NA,Africa,David Vasquez,NA,Duggal,2016,27170999,https://doi.org/10.1371/journal.pone.0155044,NA,NA,Influenza virus,Duggal 2016,193
H1N1 virus,2009-2010 H1N1 flu pandemic,prop_hospitalized_death,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",194
H1N1 virus,2009-2010 H1N1 flu pandemic,prop_critical_death,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",195
H1N1 virus,2009-2010 H1N1 flu pandemic,prop_infection_reduction_masks,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",196
H1N1 virus,2009-2010 H1N1 flu pandemic,attack_rate,0.434,NA,NA,percent,NA,NA,none provided,5_14,NA,NA,5,14,NA,China,Asia,Kate Sabey,NA,Wu,2010,NA,https://doi.org/10.1086/656740,NA,estimates for Hong Kong only based on serum antibody titers,Influenza virus,Wu 2010,197
H1N1 virus,2009-2010 H1N1 flu pandemic,attack_rate,0.158,NA,NA,percent,NA,NA,none provided,15_19,NA,NA,15,19,NA,China,Asia,Kate Sabey,NA,Wu,2010,NA,https://doi.org/10.1086/656740,NA,estimates for Hong Kong only based on serum antibody titers,Influenza virus,Wu 2010,198
H1N1 virus,2009-2010 H1N1 flu pandemic,attack_rate,0.118,NA,NA,percent,NA,NA,none provided,20_29,NA,NA,20,29,NA,China,Asia,Kate Sabey,NA,Wu,2010,NA,https://doi.org/10.1086/656740,NA,estimates for Hong Kong only based on serum antibody titers,Influenza virus,Wu 2010,199
H1N1 virus,2009-2010 H1N1 flu pandemic,attack_rate,NA,NA,NA,percent,0.04,0.046,range,30_59,NA,NA,30,59,NA,China,Asia,Kate Sabey,NA,Wu,2010,NA,https://doi.org/10.1086/656740,NA,estimates for Hong Kong only based on serum antibody titers,Influenza virus,Wu 2010,200
H1N1 virus,2009-2010 H1N1 flu pandemic,attack_rate,0.107,NA,NA,percent,NA,NA,none provided,total,NA,NA,NA,NA,NA,China,Asia,Kate Sabey,NA,Wu,2010,NA,https://doi.org/10.1086/656740,NA,estimates for Hong Kong only based on serum antibody titers,Influenza virus,Wu 2010,201
H1N1 virus,2009-2010 H1N1 flu pandemic,attack_rate,0.37,NA,NA,percent,0.3,0.44,95% confidence interval,0_4,NA,NA,0,4,NA,NA,Global,Kate Sabey,NA,Van Kerkhove,2013,NA,https://www.who.int/influenza/surveillance_monitoring/EN_GIP_WHO_H1N1pdmSerologyManuscript_2013.pdf?ua=1,NA,"reported as cumulative incidence based on the difference between pre- and post-
pandemic seroprevalence using data from 11 countries and 12 studies",Influenza virus,Van Kerkhove 2013,202
H1N1 virus,2009-2010 H1N1 flu pandemic,attack_rate,0.46,NA,NA,percent,0.36,0.56,95% confidence interval,5_19,NA,NA,5,19,NA,NA,Global,Kate Sabey,NA,Van Kerkhove,2013,NA,https://www.who.int/influenza/surveillance_monitoring/EN_GIP_WHO_H1N1pdmSerologyManuscript_2013.pdf?ua=1,NA,"reported as cumulative incidence based on the difference between pre- and post-
pandemic seroprevalence using data from 11 countries and 12 studies",Influenza virus,Van Kerkhove 2013,203
H1N1 virus,2009-2010 H1N1 flu pandemic,attack_rate,0.2,NA,NA,percent,0.13,0.26,95% confidence interval,20_44,NA,NA,20,44,NA,NA,Global,Kate Sabey,NA,Van Kerkhove,2013,NA,https://www.who.int/influenza/surveillance_monitoring/EN_GIP_WHO_H1N1pdmSerologyManuscript_2013.pdf?ua=1,NA,"reported as cumulative incidence based on the difference between pre- and post-
pandemic seroprevalence using data from 11 countries and 12 studies",Influenza virus,Van Kerkhove 2013,204
H1N1 virus,2009-2010 H1N1 flu pandemic,attack_rate,0.14,NA,NA,percent,0.09,0.2,95% confidence interval,45_64,NA,NA,45,64,NA,NA,Global,Kate Sabey,NA,Van Kerkhove,2013,NA,https://www.who.int/influenza/surveillance_monitoring/EN_GIP_WHO_H1N1pdmSerologyManuscript_2013.pdf?ua=1,NA,"reported as cumulative incidence based on the difference between pre- and post-
pandemic seroprevalence using data from 11 countries and 12 studies",Influenza virus,Van Kerkhove 2013,205
H1N1 virus,2009-2010 H1N1 flu pandemic,attack_rate,0.11,NA,NA,percent,0.05,0.018,95% confidence interval,65+,NA,NA,65,NA,NA,NA,Global,Kate Sabey,NA,Van Kerkhove,2013,NA,https://www.who.int/influenza/surveillance_monitoring/EN_GIP_WHO_H1N1pdmSerologyManuscript_2013.pdf?ua=1,NA,"reported as cumulative incidence based on the difference between pre- and post-
pandemic seroprevalence using data from 11 countries and 12 studies",Influenza virus,Van Kerkhove 2013,206
H1N1 virus,2009-2010 H1N1 flu pandemic,attack_rate,0.24,NA,NA,percent,0.2,0.27,95% confidence interval,total,NA,NA,NA,NA,NA,NA,Global,Kate Sabey,NA,Van Kerkhove,2013,NA,https://www.who.int/influenza/surveillance_monitoring/EN_GIP_WHO_H1N1pdmSerologyManuscript_2013.pdf?ua=1,NA,NA,Influenza virus,Van Kerkhove 2013,207
H1N1 virus,2009-2010 H1N1 flu pandemic,attack_rate,0.35,NA,NA,percent,0.25,0.45,95% confidence interval,5_19,NA,NA,5,19,NA,Netherlands,Europe,Kate Sabey,NA,Steens,2011,NA,https://doi.org/10.1093/aje/kwr245,NA,NA,Influenza virus,Steens 2011,208
H1N1 virus,2009-2010 H1N1 flu pandemic,attack_rate,0.066,NA,NA,percent,NA,0.18,95% confidence interval,20_39,NA,NA,20,39,NA,Netherlands,Europe,Kate Sabey,NA,Steens,2011,NA,https://doi.org/10.1093/aje/kwr245,NA,NA,Influenza virus,Steens 2011,209
H1N1 virus,2009-2010 H1N1 flu pandemic,attack_rate,0.013,NA,NA,percent,NA,0.069,95% confidence interval,40_59,NA,NA,40,59,NA,Netherlands,Europe,Kate Sabey,NA,Steens,2011,NA,https://doi.org/10.1093/aje/kwr245,NA,NA,Influenza virus,Steens 2011,210
H1N1 virus,2009-2010 H1N1 flu pandemic,attack_rate,0.076,NA,NA,percent,0.036,0.11,95% confidence interval,total,NA,NA,NA,NA,NA,Netherlands,Europe,Kate Sabey,NA,Steens,2011,NA,https://doi.org/10.1093/aje/kwr245,NA,NA,Influenza virus,Steens 2011,211
H1N1 virus,2009-2010 H1N1 flu pandemic,attack_rate,0.342,NA,NA,percent,0.226,0.456,95% confidence interval,0_4,NA,NA,0,4,NA,United States,North America,Kate Sabey,NA,Reed,2012,NA,https://doi.org/10.1371/journal.pone.0048187,NA,"estimates based on data from 10 cities following second wave of pandemic
(December 2009 to January 2010)",Influenza virus,Reed 2012,212
H1N1 virus,2009-2010 H1N1 flu pandemic,attack_rate,0.533,NA,NA,percent,0.39,0.671,95% confidence interval,5_17,NA,NA,5,17,NA,United States,North America,Kate Sabey,NA,Reed,2012,NA,https://doi.org/10.1371/journal.pone.0048187,NA,"estimates based on data from 10 cities following second wave of pandemic
(December 2009 to January 2010)",Influenza virus,Reed 2012,213
H1N1 virus,2009-2010 H1N1 flu pandemic,attack_rate,0.259,NA,NA,percent,0.068,0.423,95% confidence interval,18_24,NA,NA,18,24,NA,United States,North America,Kate Sabey,NA,Reed,2012,NA,https://doi.org/10.1371/journal.pone.0048187,NA,"estimates based on data from 10 cities following second wave of pandemic
(December 2009 to January 2010)",Influenza virus,Reed 2012,214
H1N1 virus,2009-2010 H1N1 flu pandemic,attack_rate,0.113,NA,NA,percent,0.018,0.204,95% confidence interval,25_64,NA,NA,25,64,NA,United States,North America,Kate Sabey,NA,Reed,2012,NA,https://doi.org/10.1371/journal.pone.0048187,NA,"estimates based on data from 10 cities following second wave of pandemic
(December 2009 to January 2010)",Influenza virus,Reed 2012,215
H1N1 virus,2009-2010 H1N1 flu pandemic,attack_rate,0.019,NA,NA,percent,-0.1,0.155,95% confidence interval,65+,NA,NA,65,NA,NA,United States,North America,Kate Sabey,NA,Reed,2012,NA,https://doi.org/10.1371/journal.pone.0048187,NA,"estimates based on data from 10 cities following second wave of pandemic
(December 2009 to January 2010)",Influenza virus,Reed 2012,216
H1N1 virus,2009-2010 H1N1 flu pandemic,attack_rate,0.202,NA,NA,percent,0.101,0.283,95% confidence interval,total,NA,NA,NA,NA,NA,United States,North America,Kate Sabey,NA,Reed,2012,NA,https://doi.org/10.1371/journal.pone.0048187,NA,"estimates based on data from 10 cities following second wave of pandemic
(December 2009 to January 2010)",Influenza virus,Reed 2012,217
H1N1 virus,2009-2010 H1N1 flu pandemic,attack_rate,0.183,NA,NA,percent,NA,NA,none provided,total,NA,NA,NA,NA,NA,New Zealand,Australia,Kate Sabey,NA,Bandaranayake,2010,NA,https://doi.org/10.1371/journal.pone.0013211,NA,estimate adjusted for age and ethnicity standardization to national population,Influenza virus,Bandaranayake 2010,218
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,R0,1.757,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,Liberia,Africa,Cecilia Sanchez,NA,Khan,2015,25737782,https://doi.org/10.1186/s40249-015-0043-3,NA,estimate based on corrected data,Filovirus,Khan 2015,219
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,R0,1.492,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,Sierra Leone,Africa,Cecilia Sanchez,NA,Khan,2015,25737782,https://doi.org/10.1186/s40249-015-0043-3,NA,estimate based on corrected data,Filovirus,Khan 2015,220
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,R0,1.51,NA,NA,NA,1.5,1.52,95% confidence interval,NA,NA,NA,NA,NA,NA,Guinea,Africa,Cecilia Sanchez,NA,Althous,2014,25642364,https://doi.org/10.1371/currents.outbreaks.91afb5e0f279e7f29e7056095255b288.,NA,NA,Filovirus,Althous 2014,221
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,R0,2.53,NA,NA,NA,2.41,2.67,95% confidence interval,NA,NA,NA,NA,NA,NA,Sierra Leone,Africa,Cecilia Sanchez,NA,Althous,2014,25642364,https://doi.org/10.1371/currents.outbreaks.91afb5e0f279e7f29e7056095255b288.,NA,NA,Filovirus,Althous 2014,222
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,R0,1.59,NA,NA,NA,1.57,1.6,95% confidence interval,NA,NA,NA,NA,NA,NA,Liberia,Africa,Cecilia Sanchez,NA,Althous,2014,25642364,https://doi.org/10.1371/currents.outbreaks.91afb5e0f279e7f29e7056095255b288.,NA,NA,Filovirus,Althous 2014,223
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,R0,1.71,NA,NA,NA,1.44,2.01,95% confidence interval,NA,NA,NA,NA,NA,NA,Guinea,Africa,Cecilia Sanchez,NA,WHO Ebola Response Team,2014,25244186,https://doi.org/10.1056/NEJMoa1411100,NA,NA,Filovirus,WHO Ebola Response Team 2014,224
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,R0,1.83,NA,NA,NA,1.72,1.94,95% confidence interval,NA,NA,NA,NA,NA,NA,Liberia,Africa,Cecilia Sanchez,NA,WHO Ebola Response Team,2014,25244186,https://doi.org/10.1056/NEJMoa1411100,NA,NA,Filovirus,WHO Ebola Response Team 2014,225
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,R0,2.02,NA,NA,NA,1.79,2.26,95% confidence interval,NA,NA,NA,NA,NA,NA,Sierra Leone,Africa,Cecilia Sanchez,NA,WHO Ebola Response Team,2014,25244186,https://doi.org/10.1056/NEJMoa1411100,NA,NA,Filovirus,WHO Ebola Response Team 2014,226
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,R0,1.4,NA,NA,NA,1.1,1.8,95% highest posterior density,NA,NA,NA,NA,NA,NA,Sierra Leone,Africa,Cecilia Sanchez,NA,Scarpino,2014,25516185,https://doi.org/10.1093/cid/ciu1131,NA,NA,Filovirus,Scarpino 2014,227
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,R0-pre,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Filovirus,"NA NA",228
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,R0-asym,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Filovirus,"NA NA",229
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,days_presymptomatic,12.7,NA,days,mean,NA,NA,none provided,NA,NA,NA,NA,NA,NA,Democratic Republic of Congo,Africa,Yiren Hou,NA,Eichner,2011,24159443,https://doi.org/10.1016/j.phrp.2011.04.001,NA,subtype Zaire,Filovirus,Eichner 2011,230
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,days_presymptomatic,NA,NA,days,NA,2,21,range,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Rewar,2014,NA,https://doi.org/10.1016/j.aogh.2015.02.005,NA,NA,Filovirus,Rewar 2014,231
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,days_presymptomatic,12,NA,days,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,Liberia,Africa,Cecilia Sanchez,NA,Rivers,2014,NA,http://currents.plos.org/outbreaks/index.html%3Fp=48250.html,NA,NA,Filovirus,Rivers 2014,232
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,days_presymptomatic,10,NA,days,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,Sierra Leone,Africa,Cecilia Sanchez,NA,Rivers,2014,NA,http://currents.plos.org/outbreaks/index.html%3Fp=48250.html,NA,NA,Filovirus,Rivers 2014,233
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,days_presymptomatic,11.4,NA,days,mean,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,WHO Ebola Response Team,2014,25244186,https://doi.org/10.1056/NEJMoa1411100,NA,NA,Filovirus,WHO Ebola Response Team 2014,234
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,days_presymptomatic,9.9,NA,days,mean,9,11,range,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Faye,2015,25619149,https://doi.org/10.1016/S1473-3099(14)71075-8,NA,NA,Filovirus,Faye 2015,235
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,days_symptomatic,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Filovirus,"NA NA",236
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,days_infectious,15,NA,days,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,Liberia,Africa,Cecilia Sanchez,NA,Rivers,2014,NA,http://currents.plos.org/outbreaks/index.html%3Fp=48250.html,NA,NA,Filovirus,Rivers 2014,237
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,days_infectious,20,NA,days,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,Sierra Leone,Africa,Cecilia Sanchez,NA,Rivers,2014,NA,http://currents.plos.org/outbreaks/index.html%3Fp=48250.html,NA,NA,Filovirus,Rivers 2014,238
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,generation_time,15.3,NA,days,mean,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,WHO Ebola Response Team,2014,25244186,https://doi.org/10.1056/NEJMoa1411100,NA,"""we expect the generation time distribution to be nearly identical to the serial
interval distribution""",Filovirus,WHO Ebola Response Team 2014,239
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,serial_interval_sym,14.2,NA,days,NA,13.1,15.5,range,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Faye,2015,25619149,https://doi.org/10.1016/S1473-3099(14)71075-8,NA,NA,Filovirus,Faye 2015,240
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,serial_interval_sym,15.3,NA,days,mean,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,WHO Ebola Response Team,2014,25244186,https://doi.org/10.1056/NEJMoa1411100,NA,standard deviation = 9.3,Filovirus,WHO Ebola Response Team 2014,241
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,serial_interval_sym,13,NA,days,median,8,18,interquartile range,NA,NA,NA,NA,NA,NA,NA,Africa,Cecilia Sanchez,NA,WHO Ebola Response Team,2015,25539446,https://doi.org/10.1056/NEJMc1414992,NA,observed data,Filovirus,WHO Ebola Response Team 2015,242
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,serial_interval_sym,14.2,NA,days,mean,13.1,15.3,95% confidence interval,NA,NA,NA,NA,NA,NA,NA,Africa,Cecilia Sanchez,NA,WHO Ebola Response Team,2015,25539446,https://doi.org/10.1056/NEJMc1414992,NA,fitted data,Filovirus,WHO Ebola Response Team 2015,243
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,prop_asymptomatic,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Filovirus,"NA NA",244
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,prop_symptomatic,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Filovirus,"NA NA",245
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,prop_inf_fever,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Filovirus,"NA NA",246
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,prop_inf_cough,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Filovirus,"NA NA",247
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,prop_inf_hospitalized,19.7,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,Liberia,Africa,Cecilia Sanchez,NA,Rivers,2014,NA,http://currents.plos.org/outbreaks/index.html%3Fp=48250.html,NA,NA,Filovirus,Rivers 2014,248
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,prop_inf_hospitalized,19.7,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,Sierra Leone,Africa,Cecilia Sanchez,NA,Rivers,2014,NA,http://currents.plos.org/outbreaks/index.html%3Fp=48250.html,NA,NA,Filovirus,Rivers 2014,249
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,prop_inf_critical,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Filovirus,"NA NA",250
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,prop_inf_death,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Filovirus,"NA NA",251
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,prop_sym_fever,87.1,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,Africa,Cecilia Sanchez,NA,WHO Ebola Response Team,2014,25244186,https://doi.org/10.1056/NEJMoa1411100,NA,in confirmed and probable case patients,Filovirus,WHO Ebola Response Team 2014,252
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,prop_sym_cough,29.6,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,Africa,Cecilia Sanchez,NA,WHO Ebola Response Team,2014,25244186,https://doi.org/10.1056/NEJMoa1411100,NA,in confirmed and probable case patients,Filovirus,WHO Ebola Response Team 2014,253
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,prop_sym_hospitalized,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Filovirus,"NA NA",254
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,prop_sym_critical,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Filovirus,"NA NA",255
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,prop_sym_death,62.9,NA,NA,percent,61.9,64,95% confidence interval,NA,NA,NA,NA,NA,NA,NA,Africa,Cecilia Sanchez,NA,Garske,2017,28396479,https://doi.org/10.1098/rstb.2016.0308,NA,"confirmed cases in Guinea, Liberia, and Sierra Leone",Filovirus,Garske 2017,256
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,prop_sym_death,30,NA,NA,percent,28.8,30.8,95% confidence interval,NA,NA,NA,NA,NA,0.48,NA,Africa,Cecilia Sanchez,NA,World Health Organization,2015,NA,http://apps.who.int/iris/bitstream/10665/171823/1/WHO_EVD_SDS_REPORT_2015.1_eng.pdf?ua=1,NA,"among confirmed and probable infections of non-health workers in Guinea,
Liberia, and Sierra Leone",Filovirus,World Health Organization 2015,257
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,prop_sym_death,34,NA,NA,percent,30.5,38,95% confidence interval,NA,NA,NA,NA,NA,0.61,NA,Africa,Cecilia Sanchez,NA,World Health Organization,2015,NA,https://www.who.int/csr/resources/publications/ebola/health-worker-infections/en/,NA,"among confirmed and probable infections of health workers in Guinea, Liberia,
and Sierra Leone",Filovirus,World Health Organization 2015,258
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,prop_hospitalized_death,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Filovirus,"NA NA",259
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,prop_critical_death,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Filovirus,"NA NA",260
Ebola virus,2014-2016 West Africa Ebola virus disease outbreak,prop_infection_reduction_masks,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Filovirus,"NA NA",261
MERS-CoV,2012-2015 Middle East MERS outbreak,R0,0.91,NA,NA,NA,0.36,1.44,95% confidence interval,NA,NA,NA,NA,NA,NA,Saudi Arabia,Asia,David Vasquez,NA,Chowell,2015,26336062,https://doi.org/10.1186/s12916-015-0450-0,NA,2013-2015 MERS cases,Coronavirus,Chowell 2015,262
MERS-CoV,2012-2015 Middle East MERS outbreak,R0,0.45,NA,NA,NA,0.33,0.58,95% credible interval,NA,NA,NA,NA,NA,NA,Saudi Arabia,Asia,David Vasquez,NA,Cauchemez,2016,27457935,https://doi.org/10.1073/pnas.1519235113,NA,2013-2014 MERS cases,Coronavirus,Cauchemez 2016,263
MERS-CoV,2012-2015 Middle East MERS outbreak,R0,0.47,NA,NA,NA,0.29,0.8,95% confidence interval,NA,NA,NA,NA,NA,NA,NA,Asia,Cali Wilson,NA,Kucharski,2015,26132768,https://doi.org/10.2807/1560-7917.es2015.20.25.21167,NA,up to 2013 MERS cases,Coronavirus,Kucharski 2015,264
MERS-CoV,2012-2015 Middle East MERS outbreak,R0,0.5,NA,NA,NA,0.3,0.77,95% confidence interval,NA,NA,NA,NA,NA,NA,NA,Asia,Cali Wilson,NA,Poletto,2014,24957746,http://dx.doi.org/10.2807/1560-7917.ES2014.19.23.20824,NA,up to 2013 MERS cases,Coronavirus,Poletto 2014,265
MERS-CoV,2012-2015 Middle East MERS outbreak,R0-pre,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",266
MERS-CoV,2012-2015 Middle East MERS outbreak,R0-asym,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",267
MERS-CoV,2012-2015 Middle East MERS outbreak,days_presymptomatic,5,NA,days,mean,4,6.6,95% credible interval,NA,NA,NA,NA,NA,0.71,Saudi Arabia,Asia,David Vasquez,NA,Virlogeux,2016,27775012,https://doi.org/10.1038/srep35839,NA,up to 2014 MERS cases,Coronavirus,Virlogeux 2016,268
MERS-CoV,2012-2015 Middle East MERS outbreak,days_presymptomatic,5.2,NA,days,median,1.9,14.7,95% confidence interval,NA,NA,56,24,94,0.74,Saudi Arabia,Asia,David Vasquez,NA,Assiri,2013,23782161,https://doi.org/10.1056/NEJMoa1306742,NA,2013 MERS cases,Coronavirus,Assiri 2013,269
MERS-CoV,2012-2015 Middle East MERS outbreak,days_presymptomatic,5.5,NA,days,mean,3.6,10.2,95% confidence interval,NA,NA,50,NA,NA,NA,Saudi Arabia,Asia,David Vasquez,NA,Cauchemez,2014,24239323,https://doi.org/10.1016/S1473-3099(13)70304-9,NA,up to 2013 MERS cases,Coronavirus,Cauchemez 2014,270
MERS-CoV,2012-2015 Middle East MERS outbreak,days_presymptomatic,5,NA,days,median,2,14,none provided,NA,NA,50,NA,NA,NA,NA,NA,David Vasquez,NA,CDC,NA,NA,https://www.cdc.gov/coronavirus/mers/clinical-features.html,NA,CDC website information cited by microbeScope group for incubation period,Coronavirus,CDC NA,271
MERS-CoV,2012-2015 Middle East MERS outbreak,days_symptomatic,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",272
MERS-CoV,2012-2015 Middle East MERS outbreak,days_infectious,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",273
MERS-CoV,2012-2015 Middle East MERS outbreak,generation_time,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",274
MERS-CoV,2012-2015 Middle East MERS outbreak,serial_interval_sym,7.6,NA,days,median,2.5,23.1,95% confidence interval,NA,NA,56,24,94,0.74,Saudi Arabia,Asia,David Vasquez,NA,Assiri,2013,23782161,https://doi.org/10.1056/NEJMoa1306742,NA,2013 MERS cases,Coronavirus,Assiri 2013,275
MERS-CoV,2012-2015 Middle East MERS outbreak,prop_asymptomatic,12.5,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,The WHO MERS-CoV Research Group,2013,NA,http://currents.plos.org/outbreaks/index.html%3Fp=23143.html,NA,2012-2013 MERS cases,Coronavirus,The WHO MERS-CoV Research Group 2013,276
MERS-CoV,2012-2015 Middle East MERS outbreak,prop_asymptomatic,25.1,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Oboho,2015,25714162,https://doi.org/10.1056/NEJMoa1408636,NA,2014 MERS cases,Coronavirus,Oboho 2015,277
MERS-CoV,2012-2015 Middle East MERS outbreak,prop_asymptomatic,50,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,United Arab Emirates,Asia,Joy Vaz,NA,Hosani,2019,29905769,https://doi.org/10.1093/cid/ciy503,NA,NA,Coronavirus,Hosani 2019,278
MERS-CoV,2012-2015 Middle East MERS outbreak,prop_asymptomatic,81.8,NA,NA,percent,NA,NA,none provided,NA,NA,13,2,16,0.273,Saudi Arabia,Asia,David Vasquez,NA,Memish,2014,24763193,https://doi.org/10.1097/INF.0000000000000325,Middle East respiratory syndrome coronavirus disease in children,proportion of confirmed cases in study that were asymptomatic,Coronavirus,Memish 2014,279
MERS-CoV,2012-2015 Middle East MERS outbreak,prop_asymptomatic,41.9,NA,NA,percent,NA,NA,none provided,NA,9.8,NA,0.75,17,NA,NA,NA,David Vasquez,NA,Al-Tawfiq,2016,27872828,https://www.doi.org/10.5409/wjcp.v5.i4.391,Middle East respiratory syndrome coronavirus disease is rare in children: an update from Saudi Arabia,proportion of confirmed cases in study that were asymptomatic,Coronavirus,Al-Tawfiq 2016,280
MERS-CoV,2012-2015 Middle East MERS outbreak,prop_asymptomatic,53,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,0.2,Saudi Arabia,Asia,David Vasquez,NA,Amer,2018,29649550,https://www.doi.org/10.1016/j.ijid.2018.04.001,Healthcare worker exposure to Middle East respiratory syndrome coronavirus (MERS-CoV): revision of screening strategies urgently needed,proportion of confirmed cases in study that were asymptomatic,Coronavirus,Amer 2018,281
MERS-CoV,2012-2015 Middle East MERS outbreak,prop_symptomatic,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",282
MERS-CoV,2012-2015 Middle East MERS outbreak,prop_inf_fever,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",283
MERS-CoV,2012-2015 Middle East MERS outbreak,prop_inf_cough,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",284
MERS-CoV,2012-2015 Middle East MERS outbreak,prop_inf_hospitalized,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",285
MERS-CoV,2012-2015 Middle East MERS outbreak,prop_inf_critical,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",286
MERS-CoV,2012-2015 Middle East MERS outbreak,prop_inf_death,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",287
MERS-CoV,2012-2015 Middle East MERS outbreak,prop_sym_fever,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",288
MERS-CoV,2012-2015 Middle East MERS outbreak,prop_sym_cough,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",289
MERS-CoV,2012-2015 Middle East MERS outbreak,prop_sym_hospitalized,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",290
MERS-CoV,2012-2015 Middle East MERS outbreak,prop_sym_critical,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",291
MERS-CoV,2012-2015 Middle East MERS outbreak,prop_sym_death,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",292
MERS-CoV,2012-2015 Middle East MERS outbreak,prop_hospitalized_death,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",293
MERS-CoV,2012-2015 Middle East MERS outbreak,prop_critical_death,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",294
MERS-CoV,2012-2015 Middle East MERS outbreak,prop_infection_reduction_masks,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",295
MERS-CoV,2015 South Korea outbreak,R0,6.36,NA,NA,median,4.25,9.68,95% confidence interval,NA,NA,NA,NA,NA,NA,South Korea,Asia,Cecilia Sanchez,NA,Zhang,2017,28703921,https://doi.org/10.1111/irv.12467,NA,exponential growth rate,Coronavirus,Zhang 2017,296
MERS-CoV,2015 South Korea outbreak,R0,5.89,NA,NA,median,4.42,7.66,95% confidence interval,NA,NA,NA,NA,NA,NA,South Korea,Asia,Cecilia Sanchez,NA,Zhang,2017,28703921,https://doi.org/10.1111/irv.12467,NA,maximum likelihood,Coronavirus,Zhang 2017,297
MERS-CoV,2015 South Korea outbreak,R0,2.45,NA,NA,median,1.68,3.12,95% confidence interval,NA,NA,NA,NA,NA,NA,South Korea,Asia,Cecilia Sanchez,NA,Zhang,2017,28703921,https://doi.org/10.1111/irv.12467,NA,sequential Bayesian estimation,Coronavirus,Zhang 2017,298
MERS-CoV,2015 South Korea outbreak,R0,7.15,NA,NA,median,5.26,9.35,95% confidence interval,NA,NA,NA,NA,NA,NA,South Korea,Asia,Cecilia Sanchez,NA,Zhang,2017,28703921,https://doi.org/10.1111/irv.12467,NA,nowcasting method,Coronavirus,Zhang 2017,299
MERS-CoV,2015 South Korea outbreak,R0,5.19,NA,NA,mean,3.34,7.45,95% confidence interval,NA,NA,NA,NA,NA,NA,South Korea,Asia,Cecilia Sanchez,NA,Zhang,2017,28703921,https://doi.org/10.1111/irv.12467,NA,methods of Wallinga and Teunis,Coronavirus,Zhang 2017,300
MERS-CoV,2015 South Korea outbreak,R0,6.18,NA,NA,mean,2.8,14.6,95% confidence interval,NA,NA,NA,NA,NA,NA,South Korea,Asia,Cecilia Sanchez,NA,Zhang,2017,28703921,https://doi.org/10.1111/irv.12467,NA,methods of Hens et al.,Coronavirus,Zhang 2017,301
MERS-CoV,2015 South Korea outbreak,R0-pre,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",302
MERS-CoV,2015 South Korea outbreak,R0-asym,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",303
MERS-CoV,2015 South Korea outbreak,days_presymptomatic,6.9,NA,days,mean,6.3,7.5,95% credible interval,NA,NA,NA,NA,NA,0.61,South Korea,Asia,David Vasquez,NA,Virlogeux,2016,27775012,https://doi.org/10.1038/srep35839,NA,NA,Coronavirus,Virlogeux 2016,304
MERS-CoV,2015 South Korea outbreak,days_presymptomatic,7,NA,days,median,2,17,range,NA,NA,NA,NA,NA,NA,South Korea,Asia,Cecilia Sanchez,NA,Cho,2016,NA,http://dx.doi.org/10.1016/S0140-6736(16)30623-7,NA,NA,Coronavirus,Cho 2016,305
MERS-CoV,2015 South Korea outbreak,days_presymptomatic,7,NA,days,median,2,14,range,NA,NA,55,16,86,0.597,South Korea,Asia,Cecilia Sanchez,NA,Oh,2018,29506344,https://doi.org/10.3904/kjim.2018.031,NA,NA,Coronavirus,Oh 2018,306
MERS-CoV,2015 South Korea outbreak,days_presymptomatic,8.19,NA,days,NA,5.49,11.66,95% confidence interval,NA,NA,NA,NA,NA,NA,South Korea,Asia,Cecilia Sanchez,NA,Zhang,2017,28703921,https://doi.org/10.1111/irv.12467,NA,NA,Coronavirus,Zhang 2017,307
MERS-CoV,2015 South Korea outbreak,days_presymptomatic,6.1,NA,days,median,4.7,7.5,95% confidence interval,NA,NA,71,NA,NA,0.52,South Korea,Asia,Cecilia Sanchez,NA,Park,2017,28516865,http://dx.doi.org/10.3201/eid2306.160120,NA,NA,Coronavirus,Park 2017,308
MERS-CoV,2015 South Korea outbreak,days_symptomatic,8,NA,days,median,NA,NA,none provided,NA,NA,55,16,86,0.597,South Korea,Asia,Cecilia Sanchez,NA,Oh,2018,29506344,https://doi.org/10.3904/kjim.2018.031,NA,fever,Coronavirus,Oh 2018,309
MERS-CoV,2015 South Korea outbreak,days_infectious,7,NA,days,median,1,11,range,NA,NA,55,16,86,0.597,South Korea,Asia,Cecilia Sanchez,NA,Oh,2018,29506344,https://doi.org/10.3904/kjim.2018.031,NA,NA,Coronavirus,Oh 2018,310
MERS-CoV,2015 South Korea outbreak,generation_time,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",311
MERS-CoV,2015 South Korea outbreak,serial_interval_sym,12.62,NA,days,mean,NA,NA,none provided,NA,NA,NA,NA,NA,NA,South Korea,Asia,Cecilia Sanchez,NA,Zhang,2017,28703921,https://doi.org/10.1111/irv.12467,NA,SD = 4.37 days,Coronavirus,Zhang 2017,312
MERS-CoV,2015 South Korea outbreak,prop_asymptomatic,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",313
MERS-CoV,2015 South Korea outbreak,prop_symptomatic,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",314
MERS-CoV,2015 South Korea outbreak,prop_inf_fever,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",315
MERS-CoV,2015 South Korea outbreak,prop_inf_cough,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",316
MERS-CoV,2015 South Korea outbreak,prop_inf_hospitalized,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",317
MERS-CoV,2015 South Korea outbreak,prop_inf_critical,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",318
MERS-CoV,2015 South Korea outbreak,prop_inf_death,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",319
MERS-CoV,2015 South Korea outbreak,prop_inf_death,20.4,N,NA,percent,NA,NA,none provided,NA,NA,55,16,86,0.597,South Korea,Asia,Cecilia Sanchez,NA,Oh,2018,29506344,https://doi.org/10.3904/kjim.2018.031,NA,NA,Coronavirus,Oh 2018,320
MERS-CoV,2015 South Korea outbreak,prop_sym_fever,100,NA,NA,percent,NA,NA,none provided,NA,NA,71,NA,NA,0.52,South Korea,NA,Cecilia Sanchez,NA,Park,2017,28516865,http://dx.doi.org/10.3201/eid2306.160120,NA,NA,Coronavirus,Park 2017,321
MERS-CoV,2015 South Korea outbreak,prop_sym_cough,30.8,NA,NA,percent,NA,NA,none provided,NA,NA,71,NA,NA,0.52,South Korea,NA,Cecilia Sanchez,NA,Park,2017,28516865,http://dx.doi.org/10.3201/eid2306.160120,NA,NA,Coronavirus,Park 2017,322
MERS-CoV,2015 South Korea outbreak,prop_sym_hospitalized,100,NA,NA,percent,NA,NA,none provided,NA,NA,NA,NA,NA,NA,South Korea,Asia,David Vasquez,NA,Oh,2018,29506344,https://doi.org/10.3904/kjim.2018.031,NA,NA,Coronavirus,Oh 2018,323
MERS-CoV,2015 South Korea outbreak,prop_sym_critical,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",324
MERS-CoV,2015 South Korea outbreak,prop_sym_death,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",325
MERS-CoV,2015 South Korea outbreak,prop_hospitalized_death,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",326
MERS-CoV,2015 South Korea outbreak,prop_critical_death,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",327
MERS-CoV,2015 South Korea outbreak,prop_infection_reduction_masks,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Coronavirus,"NA NA",328
H1N1 virus,1918 H1N1 flu pandemic,R0,1.22,NA,NA,mean,1.21,1.23,95% confidence interval,NA,NA,NA,NA,NA,NA,USA,North America,Rebecca Borchering,NA,Grantz,2016,27872284,https://doi.org/10.1073/pnas.1612838113,NA,"data from Chicago in particular; likely an underestimate of R0 because of
immunity already in the population",Influenza virus,Grantz 2016,329
H1N1 virus,1918 H1N1 flu pandemic,R0,2,NA,NA,median,1.7,2.3,interquartile range,NA,NA,NA,NA,NA,NA,USA,North America,Andreas Handel,NA,Mills,2004,15602562,10.1038/nature03063,NA,median over 45 US cities,Influenza virus,Mills 2004,330
H1N1 virus,1918 H1N1 flu pandemic,R0,2.7,NA,NA,median,2.3,3.4,interquartile range,NA,NA,NA,NA,NA,NA,USA,North America,Andreas Handel,NA,Mills,2004,15602562,10.1038/nature03063,NA,different assumptions than above estimate,Influenza virus,Mills 2004,331
H1N1 virus,1918 H1N1 flu pandemic,R0,2,NA,NA,mean,1.4,2.8,none provided,NA,NA,NA,NA,NA,NA,NA,NA,Daniel Suh,NA,Coburn,2009,NA,https://doi.org/10.1186/1741-7015-7-30,NA,NA,Influenza virus,Coburn 2009,332
H1N1 virus,1918 H1N1 flu pandemic,R0,2.88,NA,NA,median,2.26,4.28,95% credibility,NA,NA,NA,NA,NA,NA,UK,Europe,Daniel Suh,NA,Mathews,2007,NA,https://doi.org/10.1371/journal.pone.0001220,NA,data from Royal Air Force camps,Influenza virus,Mathews 2007,333
H1N1 virus,1918 H1N1 flu pandemic,R0,1.8,NA,NA,median,1.47,2.27,interquartile range,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Biggerstaff,2014,25186370,https://doi.org/10.1186/1471-2334-14-480,"Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature",median of 51 estimates from 24 papers,Influenza virus,Biggerstaff 2014,334
H1N1 virus,1918 H1N1 flu pandemic,R0-pre,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",335
H1N1 virus,1918 H1N1 flu pandemic,R0-asym,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",336
H1N1 virus,1918 H1N1 flu pandemic,days_presymptomatic,1.3,NA,days,mean,NA,NA,none provided,NA,NA,NA,NA,NA,NA,UK,Europe,Daniel Suh,NA,Mathews,2007,NA,https://doi.org/10.1371/journal.pone.0001220,NA,data from Royal Air Force camps,Influenza virus,Mathews 2007,337
H1N1 virus,1918 H1N1 flu pandemic,days_symptomatic,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",338
H1N1 virus,1918 H1N1 flu pandemic,days_infectious,1,NA,days,mean,NA,NA,none provided,NA,NA,NA,NA,NA,NA,UK,Europe,Daniel Suh,NA,Mathews,2007,NA,https://doi.org/10.1371/journal.pone.0001220,NA,data from Royal Air Force camps,Influenza virus,Mathews 2007,339
H1N1 virus,1918 H1N1 flu pandemic,generation_time,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",340
H1N1 virus,1918 H1N1 flu pandemic,serial_interval_sym,2.3,NA,days,mean,NA,NA,none provided,NA,NA,NA,NA,NA,NA,UK,Europe,Daniel Suh,NA,Mathews,2007,NA,https://doi.org/10.1371/journal.pone.0001220,NA,data from Royal Air Force camps,Influenza virus,Mathews 2007,341
H1N1 virus,1918 H1N1 flu pandemic,prop_asymptomatic,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",342
H1N1 virus,1918 H1N1 flu pandemic,prop_symptomatic,0.38,NA,NA,median,0.28,0.6,95% credibility,NA,NA,NA,NA,NA,NA,UK,Europe,Daniel Suh,NA,Mathews,2007,NA,https://doi.org/10.1371/journal.pone.0001220,NA,data from Royal Air Force camps,Influenza virus,Mathews 2007,343
H1N1 virus,1918 H1N1 flu pandemic,prop_inf_fever,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",344
H1N1 virus,1918 H1N1 flu pandemic,prop_inf_cough,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",345
H1N1 virus,1918 H1N1 flu pandemic,prop_inf_hospitalized,7.6,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,Yang,NA,Andreasen,2008,18194088,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674012/,NA,NA,Influenza virus,Andreasen 2008,346
H1N1 virus,1918 H1N1 flu pandemic,prop_inf_critical,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",347
H1N1 virus,1918 H1N1 flu pandemic,prop_inf_death,3.1,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,Yang,NA,Frost WH. Statistics of inﬂ uenza morbidity,1920,NA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1996797/pdf/pubhealthreporig02659-0001.pdf,NA,in New London,Influenza virus,Frost WH. Statistics of inﬂ uenza morbidity 1920,348
H1N1 virus,1918 H1N1 flu pandemic,prop_inf_death,0.8,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,Yang,NA,Frost WH. Statistics of inﬂ uenza morbidity,1920,NA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1996797/pdf/pubhealthreporig02659-0001.pdf,NA,"in San Antonio,",Influenza virus,Frost WH. Statistics of inﬂ uenza morbidity 1920,349
H1N1 virus,1918 H1N1 flu pandemic,prop_inf_death,1.7,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,Yang,NA,Andreasen,2008,18194088,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674012/,NA,1918 Influenza Pandemic Summer Wave in Copenhagen,Influenza virus,Andreasen 2008,350
H1N1 virus,1918 H1N1 flu pandemic,prop_sym_fever,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",351
H1N1 virus,1918 H1N1 flu pandemic,prop_sym_cough,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",352
H1N1 virus,1918 H1N1 flu pandemic,prop_sym_hospitalized,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",353
H1N1 virus,1918 H1N1 flu pandemic,prop_sym_critical,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",354
H1N1 virus,1918 H1N1 flu pandemic,prop_sym_death,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",355
H1N1 virus,1918 H1N1 flu pandemic,prop_hospitalized_death,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",356
H1N1 virus,1918 H1N1 flu pandemic,prop_critical_death,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",357
H1N1 virus,1918 H1N1 flu pandemic,prop_infection_reduction_masks,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",358
H2N2 virus,1957 H2N2 flu pandemic,R0,1.8,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,United Kingdom,Europe,David Vasquez,NA,Vynnycky,2008,17445311,https://doi.org/10.1017/S0950268807008369,Analyses of the 1957 (Asian) influenza pandemic in the United Kingdom and the impact of school closures.,"Applied a model of the transmission dynamics of pandemic influenza to
consultation, serological and clinical data from the United Kingdom from the
1957 (Asian) influenza pandemic, to estimate the basic reproduction number (R0)",Influenza virus,Vynnycky 2008,359
H2N2 virus,1957 H2N2 flu pandemic,R0,1.65,NA,NA,median,1.53,1.7,interquartile range,NA,NA,NA,NA,NA,NA,NA,NA,Cecilia Sanchez,NA,Biggerstaff,2014,25186370,https://doi.org/10.1186/1471-2334-14-480,"Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature",median of 7 estimates from 6 papers,Influenza virus,Biggerstaff 2014,360
H2N2 virus,1957 H2N2 flu pandemic,R0,1.39,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,Netherlands,Europe,JP Schmidt,NA,Nishiura,2010,NA,doi: 10.3934/mbe.2010.7.851,NA,Unconfirmed deaths,Influenza virus,Nishiura 2010,361
H2N2 virus,1957 H2N2 flu pandemic,R0,1.7,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,United Kingdom,Europe,JP Schmidt,NA,Ferguson,2006,NA,doi:10.1038/nature04795,NA,Unconfirmed deaths,Influenza virus,Ferguson 2006,362
H2N2 virus,1957 H2N2 flu pandemic,R0,NA,NA,NA,NA,1.5,1.6,interquartile range,NA,NA,NA,NA,NA,NA,United Kingdom,Europe,JP Schmidt,NA,Vynnycky,2008,NA,https://doi.org/10.1017/S0950268807008369,NA,"Unconfirmed illness, 1.5 day latent",Influenza virus,Vynnycky 2008,363
H2N2 virus,1957 H2N2 flu pandemic,R0,NA,NA,NA,NA,1.7,1.8,interquartile range,NA,NA,NA,NA,NA,NA,United Kingdom,Europe,JP Schmidt,NA,Vynnycky,2008,NA,https://doi.org/10.1017/S0950268807008369,NA,"Unconfirmed illness, 2 day latent",Influenza virus,Vynnycky 2008,364
H2N2 virus,1957 H2N2 flu pandemic,R0,1.5,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,United Kingdom,Europe,JP Schmidt,NA,Viboud,2006,NA,https://doi.org/10.1016/j.vaccine.2006.05.067,NA,"effective, Unconfirmed illness",Influenza virus,Viboud 2006,365
H2N2 virus,1957 H2N2 flu pandemic,R0,1.65,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,United Kingdom,Europe,JP Schmidt,NA,Gani,2005,NA,http://dx.doi.org/10.3201/eid1209.041344,NA,Serology confirmed,Influenza virus,Gani 2005,366
H2N2 virus,1957 H2N2 flu pandemic,R0,1.7,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,USA,North America,JP Schmidt,NA,Longini,2004,NA,https://doi.org/10.1093/aje/kwh092,NA,Unconfirmed illness,Influenza virus,Longini 2004,367
H2N2 virus,1957 H2N2 flu pandemic,R0,NA,NA,NA,mean,1.4,1.7,"exp vs delta, 3 vs 4 day serial interval",NA,NA,NA,NA,NA,NA,"Concepcion, Chile",South America,JP Schmidt,NA,Chowell,2016,NA,DOI: 10.1111/irv.12439,NA,NA,Influenza virus,Chowell 2016,368
H2N2 virus,1957 H2N2 flu pandemic,R0,NA,NA,NA,mean,1.7,2,"exp vs delta, 3 vs 4 day serial interval",NA,NA,NA,NA,NA,NA,"Santiago, Chile",South America,JP Schmidt,NA,Chowell,2016,NA,DOI: 10.1111/irv.12439,NA,NA,Influenza virus,Chowell 2016,369
H2N2 virus,1957 H2N2 flu pandemic,R0,NA,NA,NA,mean,1.08,1.11,"exp vs delta, 3 vs 4 day serial interval",NA,NA,NA,NA,NA,NA,"Arizona, USA",North America,JP Schmidt,NA,Cobos,2016,NA,DOI 10.1186/s12879-016-1716-7,NA,NA,Influenza virus,Cobos 2016,370
H2N2 virus,1957 H2N2 flu pandemic,R0,1.5,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,southern China,Asia,JP Schmidt,NA,WHO,2017,NA,https://apps.who.int/iris/bitstream/handle/10665/259893/WHO-WHE-IHM-GIP-2017.1-eng.pdf,NA,NA,Influenza virus,WHO 2017,371
H2N2 virus,1957 H2N2 flu pandemic,R0-pre,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",372
H2N2 virus,1957 H2N2 flu pandemic,R0-asym,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",373
H2N2 virus,1957 H2N2 flu pandemic,days_presymptomatic,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",374
H2N2 virus,1957 H2N2 flu pandemic,days_symptomatic,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",375
H2N2 virus,1957 H2N2 flu pandemic,days_infectious,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",376
H2N2 virus,1957 H2N2 flu pandemic,generation_time,3.5,NA,days,median value of mean values reported,2.6,4.1,range of mean values reported,NA,NA,NA,NA,NA,NA,"Netherlands, UK, USA","Europe, North America",JP Schmidt,NA,Biggerstaff,2014,25186370,https://doi.org/10.1186/1471-2334-14-480,NA,"Estimated from studies of Netherlands, UK, USA for mainly unconfirmed illness",Influenza virus,Biggerstaff 2014,377
H2N2 virus,1957 H2N2 flu pandemic,serial_interval_sym,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",378
H2N2 virus,1957 H2N2 flu pandemic,prop_asymptomatic,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",379
H2N2 virus,1957 H2N2 flu pandemic,prop_symptomatic,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",380
H2N2 virus,1957 H2N2 flu pandemic,prop_inf_fever,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",381
H2N2 virus,1957 H2N2 flu pandemic,prop_inf_cough,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",382
H2N2 virus,1957 H2N2 flu pandemic,prop_inf_hospitalized,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",383
H2N2 virus,1957 H2N2 flu pandemic,prop_inf_critical,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",384
H2N2 virus,1957 H2N2 flu pandemic,excess deaths,0.00019,NA,proportion,NA,0.00012,0.00026,95% confidence interval,NA,NA,NA,NA,NA,NA,global,NA,JP Schmidt,NA,Viboud,2016,NA,https://doi.org/10.1093/infdis/jiv534,NA,death rates 3 and 4 times higher in 5-14 and 15-24 than among very young or old,Influenza virus,Viboud 2016,385
H2N2 virus,1957 H2N2 flu pandemic,prop_inf_death,0.19,NA,proportion,NA,NA,0.2,none provided,NA,NA,NA,NA,NA,NA,southern China,Asia,JP Schmidt,NA,WHO,2017,NA,https://apps.who.int/iris/bitstream/handle/10665/259893/WHO-WHE-IHM-GIP-2017.1-eng.pdf?sequence=1,NA,NA,Influenza virus,WHO 2017,386
H2N2 virus,1957 H2N2 flu pandemic,prop_sym_fever,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",387
H2N2 virus,1957 H2N2 flu pandemic,prop_sym_cough,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",388
H2N2 virus,1957 H2N2 flu pandemic,prop_sym_hospitalized,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",389
H2N2 virus,1957 H2N2 flu pandemic,prop_sym_critical,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",390
H2N2 virus,1957 H2N2 flu pandemic,prop_sym_death,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",391
H2N2 virus,1957 H2N2 flu pandemic,prop_hospitalized_death,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",392
H2N2 virus,1957 H2N2 flu pandemic,prop_critical_death,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",393
H2N2 virus,1957 H2N2 flu pandemic,prop_infection_reduction_masks,NA,NA,NA,NA,NA,NA,none provided,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Influenza virus,"NA NA",394
